


























The Dissertation Committee for Younghoon Kee certifies that this is the approved 
version of the following dissertation: 
 
A regulatory mechanism for Rsp5, a multifunctional 
ubiquitin ligase in Saccharomyces cerevisiae: characterization 
of its interaction with a deubiquitinating enzyme 
 
                             Committee: 
 
      
Jon Huibregtse, Supervisor 
 
      
                                        Dean Appling 
 
      
                                                             Arlen Johnson 
 
      
                                                             Tanya Paull 
 
      






A regulatory mechanism for Rsp5, a multifunctional 
ubiquitin ligase in Saccharomyces cerevisiae: characterization 




Younghoon Kee, B.S.; M.S. 
 
Dissertation 
Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fullfilment 
of the Requirements 
for the Degree of 
 
Doctor of Philosophy 
 









This dissertation is dedicated to my loving wife, Kyewon, and my parents for 
 their love, encouragement, and unconditional support that 








  v 
Acknowledgement 
 
First, I would like to extend my utmost gratitude to Dr. Jon Huibregtse for 
allowing me the opportunity to work in his lab and learn how to build a career in 
science. He has been not only my model as a successful scientific researcher but also a 
great teacher. I also wish to extend my sincerest thanks to my committee members, Drs. 
Dean Appling, Arlen Johnson, Tanya Paull, and Scott Stevens for their continuous 
support and advice during my graduate studies. I would also like to thank all the past 
and current members of the Huibregtse lab: Sylvie Beaudenon, Cathy Salvat, Melissa 
Kelley, Nancy Lyon, Anahita Dastur, Hyungchul Kim, Larissa Durfee, and William 
Munoz for their support and helpful suggestions over the years. I would also like to 
thank people outside the lab for helpful discussion and suggestions, including Velu 
Soundarapandian and Jayaram lab members, Changwon, and Zhiwha. I especially thank 
Velu for his constructive advice and much appreciated discussions during my early 
stage of the study. I also thank Dr. Klaus Linse for his support on the mass 
spectrometry analysis. I am also grateful to my friends Jeesun and Juwon, Jeongtae, 
Jeongchul, Changkeun, Insuk, Sky, Anirvan, Ram, and Lakshmi. Finally, I would like 
to thank my loving wife, Kyewon, and my lovely daughter, Yewon, for their love and 
support. 
 
  vi 
A regulatory mechanism for Rsp5, a multifunctional 
ubiquitin ligase in Saccharomyces cerevisiae: characterization 




Younghoon Kee, Ph.D 
The University of Texas at Austin, 2006 
 
Supervisor: Jon Huibregtse 
 
HECT E3 ubiquitin ligases are widely distributed from yeast to human cells and 
play important roles in many physiological processes. Rsp5, an essential HECT E3 ligase 
in Saccharomyces cerevisiae, is involved in many biological processes, including 
transcriptional activation, endocytic trafficking, mitochondrial inheritance, and RNA 
export pathways. Although Rsp5 has been shown to regulate multiple pathways targeting 
multiple substrates, mechanisms for regulating the biochemical activity of Rsp5 are 
largely uncharacterized (121, 199). To gain further insight into the regulation of this 
enzyme, I identified proteins that copurified with epitope-tagged Rsp5. Ubp2, a 
deubiquitinating enzyme, was a prominent copurifying protein. Rup1, a previously 
uncharacterized UBA domain protein, was required for binding of Rsp5 to Ubp2 both in 
  vii 
vitro and in vivo. Biochemical and genetic evidence are consistent with a model that 
Ubp2and Rup1 antagonizes Rsp5-catalyzed substrate ubiquitination. In vivo and in vitro 
experiments showed that Rsp5 and Ubp2 display strong preferences for assembly and 
disassembly of K63-linked polyubiquitination, respectively. A large fraction of the K63 
conjugates in ubp2∆ cells bound to Rsp5, and a proteomics approach was therefore used 
to identify Rsp5 substrates subject to Ubp2 regulation. Two proteins implicated in cell 
wall integrity, Csr2 and Ecm21, were identified and both proteins were efficiently K63-
polyubiquitinated by Rsp5 and deubiquitinated by Ubp2. I have also shown that cell wall 
integrity is impaired in rsp5-1 cells and this can be rescued by either ubp2∆ or rup1∆ 
mutation, suggesting that the Ubp2/Rup1 complex negatively regulates Rsp5-mediated 
cell wall homeostasis. Together, these data represent a novel regulatory mechanism for 
Rsp5 and suggest that similar mechanisms might be utilized by its mammalian 
homologues. Furthermore, this work provides a basis for studying the mechanism for 
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1. 1 Prelude 
In the early 1980s, Hershko, Rose, and Ciechanover, the three Nobel Chemistry 
laureates of 2005, proposed the multi-step ubiquitination hypothesis by isolating the E1 
ubiquitin-activating enzyme, E2 ubiquitin conjugating enzymes, and E3 ubiquitin 
ligases (31, 87). It was proposed that these enzymes work in concert and in a sequential 
manner to target substrates for ubiquitination. Since this pioneering work, there has 
been significant advancement in our understanding of the system. This system turns out 
to be far more complicated than originally appreciated and far more widespread than 
originally envisioned, as it is now estimated that approximately a quarter of the total 
proteins in yeast are ubiquitinated (171).  
Although ubiquitin was initially isolated during a search for hormones in the 
thymus that induce differentiation of lymphocytes (73), it took several years to uncover 
the role of ubiquitin in proteolysis. ATP-dependent proteolysis was first described in 
work which showed that abnormal proteins are degraded at faster rates than normal 
proteins in rabbit reticulocyte lysate (58). A year later, it was shown that the components 
responsible for the proteolysis are biochemically separable into two fractions (APF I and 
II; ATP-dependent proteolysis factors I and II), with the proteolytic activity of APF1 
dependent on APF2 (33). It was later shown that APF1 was ubiquitin (235) and APF2 
was the proteasome (234). A surprising and significant observation followed, when it was 
shown that APF-1 was covalently conjugated to proteins, generating high molecular 
weight species (32). Since this discovery, a great deal of efforts has been devoted to 
characterize the mechanisms and functions of ubiquitination.  
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Although it has been generally accepted that ubiquitination is a mark for 
destruction of the targeted proteins by proteasome, it has become evident that 
ubiquitination of proteins also plays non-proteolytic functions. One of the most intriguing 
current questions in the ubiquitin field concerns the machinery and mechanisms that 
direct the different regulatory outcomes, which remain largely uncharacterized.  
I began my Ph.D. project by characterizing factors that regulate the catalytic 
activity of Rsp5, an essential HECT domain E3 ligase in Saccharomyces cerevisiae. 
During the course of my research, I have contributed toward understanding how this 
HECT E3 is regulated by associated factors in cells. Furthermore, my work provides a 
basis for better understanding the mechanisms and functions of the synthesis of the non-
proteolytic K63-linked polyubiquitination. 
 
1.2 Ubiquitinating enzymes 
Ubiquitination of target proteins occurs as the result of a cascade of three 
classes of enzymes (174). The first step of ubiquitination involves a two-step reaction, 
catalyzed by E1 ubiquitin activating enzyme. First, ubiquitin is activated at its C-
terminus by adenylation using ATP, releasing AMP and pyrophosphate. Second, the 
carboxyl group of activated ubiquitin is subsequently attacked by the active-site 
cysteine residue of E1, forming an E1-ubiquitin thioester intermediate. The activated 
ubiquitin is subsequently transferred to the active-site cysteine of E2 ubiquitin 
conjugating enzymes, in a trans-thiolation reaction. The ubiquitins tethered to the E2s 
can be directly transferred to the lysine residues of target substrates, or the substrate 
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ubiquitination can be preceded by a third thioseter bond formation between the 
ubiquitin and the active-site cysteine residue in the E3. The ubiquitination cascade 
involving E1, E2, and E3 is known to occur in a sequential manner, as a recent report 
suggests a model that E2 must dissociate from E1 before it can interact with an E3, by 
showing that binding of an E2 to E1 is mutually exclusive to binding of E2 to E3 (55). 
Most organisms contain only one or a few E1 enzymes, a dozen or more E2 enzymes, 
and a large number of E3 ligases, forming a cascade of the biochemical pathway. E3s 
are mainly devoted to recognizing individual target substrates, and, therefore, are the 
most abundant components in the ubiquitin system to cover a wide range of target 
substrates. 
The two major classes of E3 enzymes are the RING (really interesting new gene) 
E3s (146) and the HECT (homologous to E6AP C-terminus) E3s (105). In general, the 
RING E3s refer to both the single polypeptide RING domain proteins and the multi-
protein complexes that contain the RING-finger domain subunits (174). For simplicity, 
both classes of RING E3s will be discussed together. There are additional families of 
proteins that represent minor classes of E3 ligases, such as U-box proteins and PHD 
domain proteins, as discussed below. 
HECT E3 
The HECT domain was first discovered in a series of studies on the degradation 
of p53 tumor suppressor (106, 191, 194). The initial observation showed that the levels 
of p53 proteins in the high-risk HPV (human pappilomavirus) positive cell lines are 
very low or undetectable (192). In an in vitro study, it was shown that the high-risk E6 
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proteins of HPV bind to p53 and stimulate the degradation of p53 in the 
ubiquitin/proteasome-dependent manner (194). Subsequent biochemical studies showed 
that a cellular protein named E6AP (E6-associated protein) was required for the E6-
mediated degradation of p53. It was shown that E6 and E6AP function as an E3 ligase 
complex to induce ubiquitination of p53 (106, 191). Besides its role in the degradation 
of p53, it has been shown that mutations in the gene encoding E6AP (UBE3A) are the 
cause of Angelman syndrome, a severe neurological disease (34, 189), as will be 
discussed in the final section of this chapter. Subsequent bioinformatic examination 
revealed many proteins with high similarity to the C-terminal 350 amino acids of E6AP 
(104) and studies have shown that HECT E3s play a broad spectrum of roles in many 
biological processes from yeast to human, making them one of the two major classes of 
E3 ligases. HECT E3s are mechanistically distinct from RING E3s in that they 
participate directly in the chemistry of protein ubiquitination by forming ubiquitin-
thioester intermediates (193). HECT E3s appear to be modular proteins, with the N-
terminal part of the proteins serving as a substrate recognition domain, while the C-
terminal HECT domains function as the catalytic domain. The HECT domain contains 
all the determinants required for accepting ubiquitin from the E2 and forming a 
ubiquitin-thioester intermediate (104). The crystal structure of the HECT domain of 
E6AP showed that the HECT domain adopts a bilobal structure, with an elongated N-
lobe connected to a globular C-lobe via a short hinge loop (Illustration 1.1) (102). The 
E2 binding site and the active site cysteine residue (Cys820) are located in the N-lobe 
and the C-lobe, respectively, together constituting the catalytic core of the HECT 
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domain by forming a U-shaped pocket. The Cys820 residue is located in a four-residue 
active site loop, which is positioned at the interface between the N-lobe and the C-lobe 
(102). The active-site loop is the most highly conserved region among the HECT 
domains, and it was shown that mutations in any of these four residues resulted in 
significant reduction in the formation of ubiquitin-thioster bond, suggesting that the 
contacts made by the active-site loop between the N and the C lobe is important for the 
catalytic activity. Furthermore, mutations of N-lobe hydrophobic residues surrounding 
the active-site loop reduced ubiquitin-thioester formation by more than 90%, suggesting 
that the N-lobe portion in the cleft is also critical for the activity. The transfer of 
ubiquitin from E2 to E3 requires nucleophile attack on the E2-ubiquitin thioester by the 
active site cysteine of the HECT E3. However, the crystal structure showed that the two 
active-site cysteines of E6AP and UbcH7 are separated by 41Å. Given the surprisingly 
large distance between the two active site cysteines, a major conformation shift 
between the two lobes appears to be necessary for the trans-thiolation reaction between 
the E2 and the HECT domain to occur (102). It is conceivable that the binding of a 
ubiquitin-conjugated E2 on the HECT domain might trigger a change in the relative 
orientation between the N-lobe and the C-lobe to bring the distance between the two 
cysteine residues closer. The crystal structure of the HECT domain from another HECT 
E3, WWP1, showed that the HECT domain of WWP1 closely resembles that of the 
E6AP HECT (222). Interestingly, however, the relative orientation between the N-lobe 
and the C-lobe of the WWP1 HECT differed significantly from that of the E6AP HECT, 
due to the rotation around the hinge loop connecting the two lobes. This resulted in 
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positioning of the C-lobe closer to the E2 binding site within the N-lobe, with the 
distance between the active site cysteine of the WWP1 HECT domain and that of a 
modeled E2 shortened to be 16Å. This differential conformation of the HECT domains 
appears to be possible due, at least in part, to the flexibility of the hinge region between 
the the N and C-lobes, as the mutations within the region abrogated the ubiquitin-
thioster bond formation. An attractive model explaining the necessity for flexibility 
within the HECT domain might be that, for each cycle of the ubiquitin transfer, the C-
lobe receives ubiquitin from E2 at one side of the HECT domain and transfers it to the 
substrate bound to the N-terminus, which is at the opposite side (222, 252). Importantly, 
this mechanism suggests that the interface between the N and C-lobes need to be 
rearranged. More studies are needed to better understand the structure and function of 
the HECT domain. Recently, the crystal structure was solved for the HECT domain of 
Smurf2 (169), the HECT E3 involved in TGF-β signaling pathway (201). The structure 
showed a similar overall L-shape of the N- and C-lobe, except that the distance between 
the two active site cysteines is predicted to be even farther than that of E6AP/UbcH7 























Illustration 1.1 The crystal structures of three HECT E3s. A. The detailed view of the 
E6AP HECT domain/UbcH7 complex. E6AP hect domain N lobe, C lobe, and UbcH7 
are colored in green, red, and cyan, respectively. The two active-site loops containing 
Cys residues are colored yellow. The dotted line indicates distance (41Å) between the 
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Smurf2 & modeled UbcH7                          E6AP & UbcH7    WWP1 & modeled UbcH7
 














Illustration 1.1 continued. The crystal structures of three HECT E3s. B. Comparison of 
the overall structure of three different HECT E3s. Smurf2 HECT domain revealed the 
most open L-shaped conformation between the N-lobe (red and pink) and the C-lobe 
(blue), and the WWP1 HECT domain showed the closest gap between the two active 
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RING E3 
The RING E3s are the largest known class of E3 ligases. The RING finger was 
first described as a functional module that mediates protein-protein and protein-DNA 
interaction (146). The RING domain is typified by eight cysteine and one histidine 
residues that constitute a zinc binding pocket (44). Unlike the HECT E3s, RING E3s are 
thought to promote ubiquitination of substrates by serving as bridging proteins between 
the E2s and substrates, facilitating the direct transfer of ubiquitin from E2s to lysine 
residues of substrates. A comparison of the crystal structure between the c-Cbl RING 
domain and the E6AP HECT domain bound to the same E2, UbcH7, indicated that a 
common motif in the E2 is recognized by the two different types of E3s (253). The RING 
domain ligases can be divided into two classes, either single polypeptide E3s (e.g. Mdm2) 
or multi-enzyme complexes, namely the Cullin-RING ligases (CRLs) superfamily (173). 
The archetypical CRL is the SCF (Skp1/Cdc53/Cul1/F-box) E3 complex. The SCF ligase 
consists of Rbx1 (also known as Roc1 or Htr1), Skp1, Cul1, and a F-box protein (148, 
173). Cullins are a family of proteins that are characterized by the presence of a distinct 
globular C-terminal domain (cullin homology domain), with which a RING domain 
protein Rbx1 associates, and an N-terminal domain recruits substrates by binding to Skp1 
and various adaptor proteins (173). The key feature of CRLs is that each cullin can 
associate with many different substrate adaptor proteins, forming distinct E3 ligase 
complexes that share common catalytic core components yet recognize different 
substrates. The substrate adaptor proteins include F-box proteins, BTB (broad complex, 
tramtrack, bric-a-brac) domain proteins, and SOCS/BC (suppressor of cytokine 
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signaling/elongin-BC) box proteins (115, 241). These different adaptor proteins can bind 
to different cullins, although F-box proteins require Skp1 to mediate the interaction with 
cullins (8). Due to the great diversity of substrate adapter subunits, it is possible to 
imagine that there might be more than a hundred of distinct CRLs with different substrate 
selectivity in eukaryotic cells.  
U-box E3 
The U-box containing proteins are generally considered to be the third type of 
E3 ligases. The U-box is a highly conserved ~70 amino acid domain whose structure is 
closely related to the RING domain, despite the lack of the hallmark zinc-binding 
residues of the RING finger (82). The best characterized U-box E3 ligase is yeast Ufd2, 
one of the five gene products (Ufd1-5) isolated in a genetic screen (111). The screen 
was designed to isolate mutants in the proteolytic system that disrupts degradation of an 
artificial ubiquitin fusion substrate, ubiquitin-ß-galactosidase (UFD, ubiquitin fusion 
degradation, substrate). Later, it was shown that Ufd2 functions in a non-canonical 
manner, by elongating polyubiquitin chains that were pre-synthesized by E1, E2, and an 
E3 (Ufd4) (125). Ufd2 was able to catalyze only extension of short oligo-ubiquitin 
chains on the artificial substrate, which were catalyzed by Ufd4, a HECT E3 ligase. 
Because of this distinct activity, Ufd2 was designated as “E4” (98, 125). A database 
search revealed many proteins with the conserved U-box domain and all of them have 
been shown to possess E3 ligase activities (83). It is not known whether all U-box 
containing E3s function as E4. 
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PHD domain E3 
Recent reports have shown that PHD (plant homeodomain) domain proteins can 
function as E3 ligases (36). PHD domains typically exhibit a C4HC3 (four cysteine, 
one histidine, three cysteine) signature and bind to zinc ions, with characteristics similar 
to the RING domain (1). In spite of the similarity in the core region, a structural 
analysis has revealed the differences of overall surface areas between PHD domains 
and RING domains, particularly the E2 binding regions (46). A distinct feature of PHD 
domains is that most of the PHD domain proteins identified are nuclear proteins (36) 
and many PHD domain proteins have been shown to bind to chromosomes (11). 
Consistent with the observations, the PHD domain of the nucleosome remodelling 
factor (NURF), the largest subunit of the ATP-dependent chromatin-remodelling 
complex, have been shown to mediate a direct association of the complex with the 
methylated histones (240), further suggesting that the PHD domain functions as 
chromosomal binding module. Furthermore, the recognition mediated by the PHD 
domain was shown to be preferential to specific types of methylation (134). However, 
several viral PHD domain proteins have been shown to function outside of the nucleus 
(75, 145). Human herpes virus 8 (HHV8) encodes two PHD domain containing viral 
proteins, K3 and K5, which have been shown to promote immune evasion by 
ubiquitination and down-regulation of MHC1 (major histocompatibility complex I). 
Further studies have shown that several cellular PHD domain proteins also function as 
E3 ligases in the cellular signaling pathways, including FANCL in the DNA repair 
pathway,  MITOL in the regulation of mitochondrial dynamics, and MEKK in the MAP 
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kinase pathway (79, 147, 246). Despite the fact that several PHD domain proteins have 
been demonstrated as E3s, it is still not clear whether all PHD domains function as E3 
ligases. 
E4 activities 
As mentioned above, Ufd2 has been shown to possess a specialized type of 
activity, which is distinct from other E3 ligases. This type of activity seems to exist in 
other cases besides the UFD pathway, leading to a proposal that the E4 activities 
represent a novel distinct class of ubiquitinating enzyme (98). A well characterized 
transcriptional cofactor, p300, has been shown to be required for the extension of 
ubiquitin chains on p53, which is pre-monoubiquitinated by Mdm2, leading to its 
degradation (78). Interestingly, p300 alone cannot catalyze polyubiquitination of p53, 
similar to Ufd2, further suggesting that p300 indeed possesses the so-called E4 activity.  
No domains similar to known E3 motifs, such as HECT or RING domain, are present in 
p300. CHIP (C-terminus of Hsc70-interacting protein) is another example of E4 activity. 
CHIP is a U-box containing protein with an apparent E3 ligase activity, and it has been 
shown to be capable of enhancing the ubiquitinating activity of Parkin on its substrate 
Pael receptor (Pael-R). (109). Bul1 and Bul2, two yeast proteins that bind to Rsp5 
HECT E3 ligase, were proposed to possess E4 activities (86). It has been shown that in 
the absence of Bul1 and Bul2, Rsp5 monoubiquitinates Gap1 general amino acid 
permease to deliver it to the plasmamembrane in a nitrogen-deplete condition, wherease 
Gap1 is polyubiquitinated when Bul1 or Bul2 is overexpressed. However, further 
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biochemical demonstration is needed to prove that Bul1 and Bul2 have such chain-
extending activities, as they do not contain apparent E3 ligase activities.  
As a summary, illustration 1.2 describes the complex hierarchy of the E1-E2-E3 
ubiquitinating enzymes. A growing number of reports show that additional components 
or variants are involved in the ubiquitin pathway besides the E1-E2-E3 core 
ubiquitinating enzymes, adding much more complexity to the pathway. Some of the 
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Illustration 1.2 Diagram for the enzymatic cascade of ubiquitination. Cells contain one 
or few E1, a dozen of E2s, and numerous E3s. E3 ubiquitin ligases are responsible for 
the specificity of attachment of Ub to the target protein through the recruitment of both 
an E2 thiolester and a specific substrate. More than one E2 can work with a given E3 
and several E3s can use a single E2. HECT E3s are different from RING E3s in that 
they form intermedieate thioester bonds with ubiquitin on their active-site cysteine. 
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1.3 Deubiquitinating enzymes 
Like other types of protein modifications (e.g., phosphorylation), ubiquitination 
is a reversible process, as attachment of ubiquitin to target proteins can be reversed by a 
group of enzymes called deubiquitinating enzymes (DUBs) (4). During the past few 
years, DUBs have emerged as important regulators of many physiological processes. It 
is currently estimated that there are as many as 90 DUBs in human cells (101), making 
them the second largest class of enzymes in the ubiquitin system, next to the E3 ligases. 
DUBs catalyze cleavage of the isopeptide bond between the C-terminus glycine residue 
of ubiquitin and a lysine residue of the conjugates. Another important role of DUBs is 
to generate a mature form of ubiquitin from precursors, which otherwise are 
incompetent to be conjugated to substrates, as discussed below.  
Functions of DUBs 
Because ubiquitination of proteins often leads to their degradation by the 
proteasome, DUBs can affect the stability of target proteins by removing ubiquitination 
of target proteins. The known biochemical functions of DUBs are discussed here. 
1) Processing of ubiquitin precursors  
In all eukaryotes, ubiquitins are initially produced as C-terminally extended 
precursors (4). They are either fused to ribosomal subunits or to ubiquitins as multimers 
that also have additional amino acid extensions following the last ubiquitin monomers 
(62). Although it is not clear why ubiquitin is produced as a precursor form, it might be 
to ensure high-level expression, as the ribosomal proteins to which they are fused are 
highly abundant proteins. Ubiquitin, itself, does not need to be expressed in a precursor 
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form in order to be conjugated to cellular proteins. The processing function seems to be 
redundant among DUBs, as any single deletion of DUBs in yeast is non-lethal, except 
for Rpn11 which seems to be an essential enzyme for a different reason (discussed 
below). Many DUBs have shown to be competent for this activity in vitro (4). 
2) Regenerating free ubiquitin monomers. 
One of the most important roles of DUBs is to rescue ubiquitin molecules prior 
to either proteasomal or lysosomal degradation of conjugated substrates to regenerate a 
free pool of ubiquitins. This role of DUBs seems to be important for cells to carry out 
many biological processes, as mutations of the DUBs required for recycling of 
ubiquitin result in growth defects in many different conditions (6, 133, 215). 
Ubp4/Doa4 of S. cerevisae is a membrane-associated DUB which has shown to 
function at the late endosome/prevacuolar compartment to recover ubiquitin from 
ubiquitinated membrane proteins en route to the vacuole (215). It has been shown that 
in ubp4 mutant cells, decreased viability was observed in correlation with decreased 
free ubiquitin and defective endocytosis of receptor proteins. In agreement with its 
primary role, phenotypes of the ubp4 mutant can be rescued by overexpressing free 
ubiquitin. Interestingly, increased levels of polyubiquitinated membrane cargo proteins 
were detected in the ubp4 mutants, suggesting that Ubp4-mediated deubiquitination of 
endosomal cargos is a prerequisite for their degradation in the vacuole (52). Ubp6 
(Usp14 in mammals) is a proteasome-associated DUB which has been suggested to 
rescue ubiquitin from proteosomal degradation (133). The ubp6 mutant cells exhibit a 
severe growth defect under many conditions, which can be rescued by overexpressing 
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ubiquitin, thereby suggesting that the phenotypes are due to depletion of free ubiquitin 
(27).  
3) Reversing substrate ubiquitination 
Degradation of ubiquitinated proteins by the 26S proteasome obviously is an 
irreversible process. The dynamic regulation of substrate ubiquitination and 
deubiquitination seems to be important for many substrates. I describe several examples 
where DUBs function as critical regulators of given pathways. 
 CYLD (Cylindromatosis), the first DUB linked to a human genetic disorder, 
familial cylindromatosis (12), was shown to have a tumor-suppressive role by 
inactivating the NF-kB pathway (17, 127, 220). TRAF2 and TRAF6 (TNFR-associated 
factor 2 and 6, respectively), the heterodimeric adapter proteins that bridge the 
interaction between TNF receptors and the downstream proteins, possess the RING 
domains and ubiquitinate multiple substrates in the pathway, including themselves (26). 
It was shown that CYLD, by associating with the E3 complex, deubiquitinates multiple 
targets in the complex including the auto-ubiquitinated E3s, thereby inactivating the 
NFkB pathway. It appears that a loss of CYLD activity in the deubiquitination of the 
targets in the NFkB pathway is the underlying mechanism for the cylindromatosis. 
More recently, CYLD was also shown to deubiquitinate Bcl-3, thereby preventing its 
translocation into the nucleus and stimulation of NF-kB mediated-transcriptional 
activation (153). These data suggests that CYLD inhibits different steps of the NF-kB 
pathway by deubiquitinating multiple substrates within the pathway. 
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FANCD2, the key mediator protein in the FA (Fanconi Anemia) pathway, is 
monoubiquitinated upon DNA-damage and localizes into the nucleus to facilitate DNA 
repair (38). It was found that USP1 (ubiquitin specific protease 1) is a critical regulator 
of the FA pathway (167). It was shown that deubiquitination of FANCD2 by USP1 is 
required for the recycling of the nuclear protein back to the cytoplasm, which inhibits 
further activation of DNA repair. Conversely, persistent monoubiquitination of 
FANCD2 in the USP1-depeleted cell is likely to result in hyper-activation of the FA 
pathway and chromosomal aberrations. USP1 was also shown to deubiquitinate PCNA 
(proliferating cell nuclear antigen), monoubiquitination of which is required to 
safeguard against error-prone translesion DNA synthesis (103).  
Regulation of p53 activity is achieved by many types of modifications, 
including ubiquitination. It was shown that Mdm2-mediated ubiquitination of p53, 
which leads to destabilization of the protein, can be reversed by a deubiquitinating 
enzyme HAUSP (herpesvirus-associated ubiquitin specific protease; also known as 
USP7), thereby leading to stabilization of p53 (137). However, a more recent study has 
shown the opposite result, that stabilization and activation of p53 were observed when 
HAUSP was disrupted in human cells (37).  It was also shown that HAUSP 
deubiquitinates Mdm2, which results in stabilization and activation Mdm2, that, in turn, 
leads to the destabilization of p53. The pathway seems to be far more complicated than 
once thought, with the contribution of several other factors have also been shown in the 
multi-faceted pathway (16, 159).  
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Taken together, it is evident that the deubiquitination of proteins by DUBs is a 
crucial mechanism for regulating many pathways, and it is likely that DUBs are widely 
used in other processes as well. It is interesting to note that CYLD, USP1, and HAUSP 
all have multiple substrates in their repsective pathways to deal more effectively with 
the corresponding signals. Significantly, activities of many DUBs have shown to be 
strictly regulated by different signaling events (85, 103, 108, 159). 
4) Disassembly of free polyubiquitin chains 
 Accumulation of excessive free polyubiquitin chains in the cells can inhibit 
proteosomal degradation and eventually become toxic to cells (3). This can be due 
either to limited available ubiquitin monomers or competitive inhibition of binding of 
polyubiquitinated substrates to the proteasome (3). These free unanchored chains are 
likely to be the byproducts of proteosomeal degradation, as the polyubiquitin chains 
must be removed from substrates and cleaved into monomers for recycling, prior to 
substrate degradation. Cells seem to have developed specialized DUBs to cope with this 
potential problem, as Ubp14 in S. cerevisae (Isopeptidase T in mammalian cells) has 
been shown to disassemble, preferentially, the bulk of unanchored free chains (3). 
Interestingly, Ubp14 has been shown to remove ubiquitins from the proximal end of the 
chain (the ubiquitin with free glycine carboxyl group) and has also been shown to have 
marked preference to unanchored free chains in vitro, consistent with its demonstrated 
role in the proteasome pathway. Although yeast cells deficient in Ubp14 display 
increased free polyubiquitin chains and inhibition of proteosomal degradation of 
substrates, they seem to be viable under normal conditions, although ubp14∆ cells are 
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highly sensitive to canavanine. However, its orthologs in Dictyostelium and 
Arabidopsis, UbpA and AtUBP14, respectively, which can functionally replace yeast 
Ubp14, were shown to be essential during the early development of each organism (47, 
141). However, cells with deficient Ubp14 inhibited proteasomal degradation of only 
selective substrates, suggesting that redundant DUBs exist for free chain disassembly in 
the proteasomal degradation pathway (54), consistent with the fact that the ubp14∆ 
cells are viable. 
Classes of DUBs 
There are at least five subgroups of DUBs characterized to date, based on their 
sequence similarities and biochemical activity. Four of the five groups of DUBs are 
cysteine proteases and one group contains metal-dependent proteases. 
1) UCHs and UBPs 
Ubiquitin C-terminal hydrolases (UCHs) and ubiquitin specific proteases (UBPs) 
are two major groups of DUBs. UCHs are generally small proteins (20-30kDa) that 
preferentially cleave ubiquitins from small adducts such as ubiquitin precursors (4). 
Although UCHs were the first known DUBs, their physiologic functions and substrate 
specificities are poorly understood. The best characterized UCH member is UCH-L1, 
the neuron-specific protease. UCH-L1 has been presumed to be critical for cytoplasmic 
protein degradation and ubiquitin recycling and has been linked to Parkinson’s disease 
(142). Recently, it was found that the level of UCH-L1 was low in AD (Alzheimer 
disease) model mice and UCH-L1 was shown to be required for normal synaptic 
function and cognition function (74).  
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Compared to UCHs, UBPs are much larger in size (60-300kDa) and seem to 
have a wider range of substrate specificity. It is estimated that more than 80% of total 
DUBs are UBPs (30). In S. cerevisiae, 16 of 18 DUBs characterized are UBPs, 
including Ubp2, which will be discussed in detail in this dissertation. The rest of the 
DUBs in budding yeast include a UCH family protease and a JAMM motif protease. 
UBP members do not exhibit high sequence homology, unlike relatively well conserved 
UCHs. The only conserved regions detected are the two short stretches of highly 
conserved sequences, termed the Cys box, which generally comprises of up to 19 amino 
acids that contain the highly conserved “GxTCY” signature, and the His box, which 
generally contains 60-90 amino acids with a conserved “GHY” signature (4, 101). 
Together with the conserved Asp residue, these domains form a “catalytic triad”(4). 
The crystal structures of representative members of both UCHs and UBPs have been 
solved  for both free enzymes and the enzmymes in a complex with ubiquitin (101, 112). 
In order to isolate stable complexes, both studies used ubiquitin aldehyde (Ubal), which 
forms a relatively stable hemithioacetal intermediate with the active-site cysteine (88, 
101). These studies revealed several interesting common features between UCHs and 
UBPs. First, the structures of the catalytic core triad are closely related to each other 
and are superimposable to that of other cysteine protease such as papain (4, 101, 112). 
Secondly, the conformation of the catalytic cores are switched to active forms, in which 
the the catalytic Cys, His, and Asp residues are close together, only when the Ubal was 
complexed, suggesting that they undergo a conformational change upon binding to 
ubiquitin. Together with the fact that the sequences that form this catalytic triad have 
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been shown to be highly conserved with other representative UCHs and UBPs, the 
structure data strongly suggest that mechanisms of proteolysis among UBPs are quite 
similar. The rest of the sequences are highly divergent, generally containing long 
extended sequences, whose functions are largely uncharacterized, although it is 
assumed that those non-conserved sequences might be responsible for determining 
substrate specificities. Consistent with this, the N-terminus divergent domain of 
HAUSP has been shown to interact with its substrate, p53 (101).  
2) OTU proteases 
 OTU (ovarian tumor)-related proteases are a recently discovered family of 
cysteine proteases, initially predicted in a bioinformatic study that found a set of 
proteins that contain sequences similar to other cysteine proteases  (150). It was 
suggested that the predicted structures of these proteases are unrelated to previously 
known proteases. Based on sequence analysis, it was suggested that conserved 
sequences surrounding cysteine and histidine comprise a catalytic dyad which is 
indispensable for the biochemical activities, similar to the UBP family proteases. 
Subsequent reports have shown that the OTU family proteases are indeed ubiquitin 
proteases. Cezanne (cellular zinc finger anti-NF-kB) was the first described OTU 
protease with deubiquitinating activity, shown by in vitro cleavage of ubiquitin 
monomers from synthetic chains and substrates (60). The best characterized OTU 
domain-containing protein is A20, a potent negative regulator of the NF-kB pathway. 
Interestingly, it was found that A20 contains two opposite ubiquitin-editing activities, 
the N-terminal OTU deubiquitinating domain and the C-terminal zinc-finger sequences 
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with E3 ligase activity (232). It has been shown that the sequential deubiquitination and 
ubiquitination of its substrate RIP (receptor interacting protein) by A20 is required for 
inhibiting downstream events in the NF-kB pathway. Otubain 1 and Otubain 2, two 
OTU domain proteases recently identified using Ubal as a trap, have been shown to 
exhibit deubiquitinating activity against Ub-GFP fusion in vitro (9). 
3) Josephin domain proteases 
The Josephin domain, named after Machado-Joseph (MJ) disease, is a conserved 
monomeric domain which folds into a globular conformation and possesses 
deubiquitinating activity (29). A bioinformatic study has revealed that the Josephin 
domain is present in at least 30 predicted proteins (151). The best characterized Josephin 
domain containing protein is Ataxin-3. Ataxin-3 belongs to the family of polyglutamine 
proteins, which are associated with nine different neurodegenerative disorders, and it 
contains the N-terminal Josephin domain followed by two ubiquitin interacting motifs 
(UIM) domain, poly-Q stretch, and a short variable tail (151). The poly-Q stretch has 
been shown to to mediate the interaction with VCP/p97 , an ATPase involved in protein 
quality controls in ER (93, 154), suggesting a role of Ataxin-3 in protein quality control. 
The NMR structure of Ataxin-3 has demonstrated conserved characteristics of other 
cysteine proteases which are represented by the catalytic triad that includes cysteine, 
histidine, and aspartate. The chemical shift data have also revealed that the Josephin 
domain can bind to ubiquitin by itself.  The UIM domains are thought to be linked to the 
DUB activity and to recruit polyubiquitin chains for orienting the substrates for efficient 
cleavage. Thus, it has been proposed that Ataxin-3 functions as a polyubiquitin chain-
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editing protease (151) and, recently, the deubiquitinating activity of Ataxin-3 was shown 
to facilitate degradation of misfolded ERAD (ER-associated degradation) substrates, 
possibly by editing the chain length of the substrates (228). 
4) JAMM motif proteases  
JAMM (JAB1/MPN/Mov34 metalloenzyme) motif proteases are distinct from the 
rest of the DUBs in that they are zinc-dependent metalloproteases, not cysteine proteases. 
They share a distinct conserved, putative metal-binding motif, called the JAMM motif (2). 
The metalloprotease activity depends on absolutely conserved His and Asp residues, both 
of which constitute a zinc-binding pocket (4). The best characterized enzymes that fall 
into this group are Rpn11/POH1 and Csn5, which are intrinsic components of  
proteasome and COP9 signalosome (CSN), respectively (4). The lid of 19S proteasome 
and CSN are closely related complexes, with Rpn11 and Csn5 as the subunits that are 
most closely related to the two complexes (2). The JAMM motif of Rpn11 seems to be 
essential for its activity, as mutation in the motif stabilized ubiquitinated substrates and 
rendered yeast cells lethal (223). Since Rpn11 was found to be associated with the 
proteasome, it has been suggested that the deubiquitination step by Rpn11 is essential for 
proteasomal degradation of substrates. CSN, the multi-functional complex that cleaves 
Nedd8 from cullin, is required for activation of the cullin-based SCF E3 ligase complex. 
It was found that the JAMM motif in the Csn5 subunit is the underlying Nedd8-cleaving 
activity of CSN (35). More JAMM motif proteases have been found, such as AMSH 
(associate molecule with SH3 domain of STAM), whose protease activity is involved in a 
negative regulation of receptor endocytosis (157). 
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1.4 Ubiquitin binding domains 
One of the most important questions in the ubiquitin field that remains largely 
unanswered is how ubiquitination is transmitted to the downstream events. Owing to 
the past few years of extensive studies on the accessory components in the ubiquitin 
pathways such as ubiquitin binding domains (UBDs), we are beginning to unravel the 
mysteries of ubiquitin-mediated signal transduction.  
UBDs are independently folded modular domains that non-covalently bind to 
ubiquitin (92). The first ubiquitin binding site to be characterized was a subunit in the 
26S proteasome, S5a (Rpn10 in yeast) (45, 247). The 30 amino acids in the C-terminus 
of the protein, now known as the ubiquitin interacting motif (UIM), were shown to be 
sufficient and necessary for binding to a hydrophobic surface of ubiquitin (247). 
Significantly, it was shown that the S5a subunit displays selective affinity towards 
polyubiquitin chain, as opposed to monoubiquitin, consistent with its role in the 
recognition of polyubiquitinated proteasomal substrates. The information from this 
work was used to perform subsequent bioinformatic studies and revealed several UIM-
containing proteins in the proteosomal and lysosomal systems (96, 176). The Ubiquitin-
associated domain (UBA) was first identified in another bioinformatic study (95) and 
was later found to be capable of binding to ubiquitin as well (233), representing the 
second UBD to be characterized. The latter work first described that Rad23 and Dsk2, 
two major proteins involved in delivering K48-linked polyubiquitin chains to 
proteasome, contain UBA domains. Other UBDs have been characterized over the past 
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few years, some of them by using proteomics approaches that have led to identification 
of the CUE (coupling ubiquitin to endoplasmic reticulum degradation) (204) domain, 
the GAT (gga and tom1) (203) domain, the PAZ (polyubiquitin-associated zinc finger) 
domain (198), the VHS (vps27, hrs, sTAM) domain (162), the NZF (npl4 zinc finger) 
domain (160), the GLUE (gRAM-like ubiquitin-binding in eap45) domain (205), and 
the UEV (ubiquitin conjugating enzyme variant) domain (70).  
Although the presence of UBDs suggests that the proteins may function in the 
ubiquitin binding, functional relevance of the proteins in the given pathways remains 
largely uncharacterized. So far only few roles of the UBD-containing proteins are 
ascribed to the UBDs in S. cerevisae, and most seem to have roles in recognizing 
endocytic cargo and polyubiquitinated substrates in proteasomal pathway. The fact that 
some of the deubiquitinating enzymes (e.g. Ubp14), a RNA helicase (YHR419W), and 
a metabolic enzyme (Gts1) also contain UBDs (92) suggests that UBDs might have 
broader roles outside the endocytic and proteasomal pathways. UBDs are often found in 
combination with various other domains, further suggesting that ubiquitin binding is 
involved in many processes. 
The best characterized UBD-containing protein is yeast Rad23 (mammalian 
hHR23A). Rad23 contains an N-terminal UBL (ubiquitin-like) domain and two UBA 
domains in the middle and C-terminus of the protein, and Dsk2 has an N-terminal UBL 
domain and C-terminal single UBA domain. Rad23 was originally characterized for its 
role in nucleotide excision repair (161). Recently, however, it was shown that the UBA 
domains of Rad23 have an important role in binding to polyubiquitinated proteins (24). 
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Furthermore, the ERAD (ER-associated protein degradation)-associated E3 ligase Ufd2 
and the Rpn1 proteasomal subunit compete for binding to the UBL domain of Rad23, 
suggesting that Rad23 is a shuttling protein that couples between substrate 
ubiquitination and delivery to the proteasome by having two different UBDs (56, 124). 
Importantly, yeast cells lacking UBA domains of both Rad23 and Dsk2 are defective in 
proteolysis of UFD substrates, suggesting that they cooperate, perhaps redundantly, to 
recognize a subset of the polyubiquitinated chains and deliver them for proteasomal 
degradation (179). Also, a genetic screen identified Rad23 and Dsk2 as essential 
proteins for ERAD (158), further suggesting that they are widely used essential 
shuttling proteins for delivery of polyubiquitinated proteins. 
 Related to the fact that Rad23 specifically recognizes polyubiquitinated 
proteins destined for proteosomal degradation, an important question is how UBA-
domains recognize different forms of ubiquitin chains, such as K48 or K63-linked 
polyubiquitins or monoubiquitin. The systematic analysis of the polyubiquitin chain-
interaction properties of 30 UBA domains showed that some UBA domains display 
linkage-selective polyubiquitin binding and some domains bind different chains, and 
monoubiquitin, in a nondiscriminatory manner (178). For example, the second UBA 
domain of Rad23 was shown to bind to K48-linked chains in preference to K63-
linkages, consistent with Rad23’s demonstrated role as a shuttle protein in the 
proteasomal degradation. However, some of the UBA domains that have been shown to 
be involved in proteasomal degradation have demonstrated non-selective preference to 
different chain types, raising the possibility that the full-length proteins might behave 
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differently than their individual UBA domains due to the presence of other domains in 
the proteins. In general, there is a wide range of affinities between UBDs and their 
substrates, although the affinities are shown to be very low, with typical Kds ranging 
from 10 to 500uM (92). The inherent low affinities of the UBDs to ubiquitin may 
reflect the dynamic nature of the physiologic interactions that enable the ordered 
transfer of ubiquitinated substrates to acceptors. 
 
1.5 Polyubiquitin chain types 
Ubiquitin has seven internal lysines (K6, K11, K27, K29, K33, K48, and K63) 
and all have shown to be capable of accepting ubiquitin molecules to form 
polyubiquitin chains in cells, as demonstrated by mass spectrometry analyses of 
purified ubiquitin conjugates from cells (171, 216). Recently, types of polyubiquitin 
chain linkages have become an important topic in the ubiquitin field due, in part, to 
increasing evidence that non-proteolytic linkages (e.g. K63-linkages) play important 
roles in physiological processes. The consequence of polyubiquitination depends on 
which lysine was used for synthesizing the polymer. K48-linkages are considered to be 
the major type of polyubiquitin chain and lead to degradation of the conjugates by 
proteasome (21). Consistent with its essential role in proteasomal degradation, K48 has 
been shown to be the only lysine residue in ubiquitin essential for the viability of yeast 
cells, although mutations of other lysines moderately affect cell growth (208).  
K63-linkages are probably the second most abundant chain type in cells and 
have been implicated in several processes, with the best characterized role being in 
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DNA repair (97, 208). The underlying basis for the role of K63-linkages in DNA repair 
has been shown to involve PCNA (proliferating cell nuclear antigen), a DNA-
polymerase sliding clamp involved in DNA synthesis and repair, and it has been shown 
that K63-linked polyubiquitination of PCNA is required for error-free DNA replication 
upon DNA damage (94), by blocking the activity of error-prone TLS (translesion 
synthesis) polymerases (28). Furthermore, cells deficient in K63-linkages have been 
shown to be hypersensitive to UV-induced mutation and DNA-crosslinking agents (28), 
further suggesting that the K63-linkages play critical roles in maintaining the genomic 
integrity. The K63-linked polyubiquitination of PCNA was found to be catalyzed by an 
E2 heterodimer complex that consists of Ubc13 and Mms2, a yeast E2 variant (UEV; 
homologs of E2s that lack active site Cys) (97). The question as to how K48 or K63-
linkages are selectively assembled by specific enzymes remains one of the important 
challenges in the field. A recent structural analysis of Mms2/Ubc13 complex suggested 
that Mms2 might have a role in allowing selective accession of K63 of donor ubiquitin 
into the active site pocket of Ubc13, promoting nucleophile attack of acceptor thioester 
bond selectively by the K63 residue (53). 
Another well characterized pathway that involves K63-linked 
polyubiquitination is NF-kB signaling pathway (43, 116). During the NF-kB activation, 
proteasome-dependent IkBα degradation is triggered by IKK (IKß kinase) complex-
mediated phosphorylation and ubiquitination of IkBα (197). How IKK is activated had 
been mysterious until the discovery that IKK activation is dependent on K63-linked 
polyubiquitination on several key regulators in the pathway (43). It was shown that 
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upon cellular stimulation, TRAF2 and TRAF6, heterodimeric RING E3s in the pathway, 
undergo K63-linked autoubiquitination and ubiquitinate other targets. Instead of 
inducing proteasomal degradation, the K63-polyubiquitinations lead to the enhanced 
phosphorylation of IkBα, which is indicative of the activated IKK. One of the initial 
targets is an adaptor protein RIP (receptor interacting protein), and the modified RIP 
recruits NEMO, a regulatory subunit of the IKK complex, and TAK kinase complex. 
Subsequently, the recruited IKK complex is activated by TAK kinase-mediated 
phosphorylation (225), which in turn phosphorylates IkBα. Recently, it was shown that 
NEMO displays strong preferential binding to K63-linkages over K48-linkages, and a 
defective binding of NEMO to the polyubiquitinated RIP results in the proteasome-
dependent degradation of RIP (238). Interestingly, it was shown that the K63-
polyubiquitinated RIP is destabilized by A20, a dual function protein with a DUB and a 
E3 activities, which deubiquitinates the K63-linkages and subsequently ubiquitinates 
via K48-linkages (232). Conceivably, the NEMO binding of polyubiquitinated RIP 
might protect RIP from being targeted by A20. Notably, K63-linked polyubiquitination 
in the NF-kB pathway is also dependent on the Ubc13/Uev1A E2 complex (Mms2 in 
yeast), suggesting that the Ubc13/Uev1A is involved in more than one pathway 
involving K63-linkages.  
Other processes that involve K63-linked polyubiqiuitination include Rsp5-
mediated receptor endocytosis (66, 206), Rsp5-mediated mitochondrial inheritance (64), 
Rsp5-mediated cell wall biogenesis (121), and a potential regulation of ribosomal 
function (by an unknown conjugating enzyme) (207). Although it has been shown that 
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K63-linked polyubiquitination of certain substrates lead to proteasomal degradation in 
vitro (187), whether or not that reflects what naturally happens in the cells remains to 
be determined. The solution structures of K63-linked di-ubiquitin have been shown to 
be significantly different from that of K48-linked di-ubiquitin (Illustration 1.3). The 
K48-linked di-ubiquitin adopts a closed conformation with possible intra-molecular 
interactions between the surface hydrophobic residues (L8, V70, I44) of ubiquitin 
whereas the K63-linked di-ubiquitin adopts an extended conformation with no intra-
molecular contacts. This apparent structural difference between the two types of chains 
























Illustration 1.3 Solution structures (NMR) of K48-linked di-ubiquitin (top) and K63-
linked di- ubiquitin (bottom). The lysine residues are shown red and the surface 
hydrophobic residues (L8, V70, I44) are shown in cyan and gold. Reprinted from 
Pickart and Fushman (175). Copyright (2004), with permission from Elsevier. 
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Several enzymes have been shown to be capable of catalyzing K29-linked 
chains in vitro, including two HECT E3s Ufd4 (188) and KIAA10 (229), although the 
biological relevance of the polyubiquitination still remains elusive. A potential link 
between K29-linkages and receptor endocytosis was suggested in a recent report (19). 
This work showed that Itch, a mammalian homologue of Rsp5, catalyzes K29-linked 
polyubiquitination of Deltex, a positive regulator of the Notch signaling pathway, 
thereby facilitating the down-regulation of the substrate via endocytosis. 
Other types of chain linkage remain largely uncharacterized, including K6-
linked chains, whose only biological implication was assigned in the BRCA1/BARD1 
E3 complex-mediated  autoubiquitination (237). The biological relevance of the K6-
linkages and substrates are unknown. 
 
1.6 Functions of Rsp5 
Rsp5 is an essential HECT E3 ligase in S. cerevisiae that belongs to the Nedd4 
(neural precursor cell-expressed developmentally downregulated gene 4) family of 
HECT E3 proteins. The Nedd4 family proteins share highly related domain 
organizations and exist from yeast to human (186). Nedd4 family proteins consist of an 
N-terminal C2 domain, which is a Ca2+/lipid binding domain, two to four WW 
domains, which have an affinity for proline-rich sequences, and the C-terminal HECT 
domain. There are multiple Nedd4 members in mammals, Drosophila, C. elegans, and 
Schizosaccharomyces. pombe, while there is only one homologue in S. cerevisae (201). 
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Studies over the past decade have shown that Rsp5 is involved in numerous 
biological pathways and contains multiple substrate specificities. Rsp5 was first 
implicated in transcriptional regulation, as a temperature sensitive mutant (rsp5-1; 
reverse of spt3 phenotype 5) was isolated to be a suppressor of a spt3 mutant  
phenotype (Fred Winston and colleagues, unpublished; cited in (104)). Spt3 is a 
component of the SAGA (Spt/Ada/Gcn/acetyltransferase) complex which activates 
transcription of many genes (76). Although direct physical interaction between Rsp5 
and the transcription factors have not been reported, the genetic interaction suggested 
that Rsp5 might have a nuclear function. Other studies have shown that Rsp5 is 
involved in numerous biological pathways at multiple locations (50, 51, 66, 117, 182, 
206, 226). Consistent with this, the mutants of RSP5 were isolated from multiple 
genetic screens. So far the well established roles of Rsp5 include transcriptional 
activation, regulation of endosomal trafficking, RNA export (66, 99, 166). Here I 
summarize some of the well characterized roles of Rsp5. 
The OLE pathway 
Although ubiquitination has been implicated in transcriptional regulation in the 
nucleus by direct ubiquitination of histones or transcriptional machinery (163), it has 
been shown that Rsp5 mediates transcriptional regulation at the ER membrane (99). 
This study isolated OLE1 as a multi-copy suppressor of the cells with deficient Rsp5 
activity (expressing catalytically inactive dominant-negative rsp5 C-A mutant). OLE1 
encodes an essential ∆9 fatty-acid desaturase, a key enzyme synthesizing unsaturated 
oleic acid. The production of oleic acid is critical for preserving the integrity of 
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membranes and viability of cells, however, the ole1∆ mutant can be rescued by simply 
supplementing the oleic acid in the growth media (214). It was shown that when the 
levels of the unsaturated fatty acids in the ER fall, Spt23, the ER-bound transcription 
factor, becomes ubiquitinated by Rsp5. Strikingly, rather than being degraded by the 
proteasome, the ubiquitinated Spt23 is specifically cleaved in a proteasome-dependent 
manner. The processed N-terminal fragment of Spt23, being liberated from the ER 
membrane, enters the nucleus to induce the Ole1 expression, which catalyzes 
production of unsaturated fatty acids. How the proteasomal activity is controlled to 
process Spt23 is unknown, however, this demonstrated that a proteolytic activity of the 
proteasome can cleave proteins with precision and specitficity. Rsp5 has also been 
shown to mediate proteasomal activation of Mga2, another ER-bound transcription 
factor with an overlapping function with Spt23 (99, 200). This OLE pathway represents 
the minimal essential function of Rsp5 in S. cerevisiae at normal growth temperature. 
Endosomal trafficking 
Studies have shown that the main functions of the Nedd4-family members of 
HECT E3 ligases are modulation of the activity of membrane receptor proteins (186). 
Rsp5 has been shown to down-regulate multiple plasmamembrane proteins, including 
Fur4 (uracil permease) (66), Gap1 (general amino acid permease) (84), and Ste2 (α-
factor receptor) (50). Rsp5 has shown to be involved in regulation of both endocytosis 
of receptor proteins and of biosynthetic cargo such as vacuolar proteases Cps1 (117) 
and Phm5 (90). The C2 domain is generally thought to recruit Rsp5 to membranes and 
facilitate the interaction between Rsp5 and its membrane-associated substrates. It has 
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been shown that the C2 domain is necessary for the down-regulation of Fur4 (226). 
Additionally, the C2 domain seems to be indispensable for the sorting of biosynthetic 
vacuolar enzymes (51, 117). Rsp5 has also been shown to be recruited to the 
biosynthetic compartment by Bsd2, a PPxY-motif containing adapter protein (90), 
suggesting that Rsp5 is recruited to the membrane substrates via two independent 
mechanisms. Rsp5 seems to be required for multiple steps in the endocytic pathway, as 
it has been shown that an rsp5 mutant is still defective in the internalization of Ste2-
ubiquitin fusion, a chimeric receptor protein that does not require ubiquitination (50). 
Consistent with this observation, the GFP-Rsp5 fusion protein has been shown to be 
present in multiple locations in the endocytic pathway (226), further suggesting that 
Rsp5-mediated ubiquitination is required more than at the initial step for receptor 
internalization. Rsp5 has shown to down-regulate a number of other receptor proteins, 
including Hxt6 and Hxt7 glucose transporters (128), Zrt1 zinc transporter (72), and 
Tat1 tryptophan transporter (164). (see Table 1). 
The Rsp5-mediated endocytosis of membrane proteins represents one of the 
well characterized role of the K63-linked polyubiquitination (66, 206). Despite the 
obvious requirement of K63-linkages in the endocytosis, monoubiquitination appears to 
be minimally functional in the internalization of Gap1 and Fur4. Consistent with this, 
the inframe fusion of ubiquitin to Ste2 lacking tail lysine residues have been shown to 
undergo rapid internalization, suggesting that monoubiquitination is sufficient for the 
receptor internalization (218). Therefore, it is possible that Rsp5 mediates both types of 
modification on the membrane proteins. 
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RNA export 
The first link between the ubiquitin system and the RNA export pathway was 
described in a study that found a mutant in the E1 enzyme is defective in mRNA export 
in S. pombe. Subsequent studies using S. cerevisiae found that two HECT E3s, Tom1 
and Rsp5, are the major E3 components in the ubiquitin-mediated RNA export pathway 
(48, 183). Additionally, a separate study using a genetic screen for isolating mutants 
with defective RNA export identified an rsp5 mutant (166), further suggesting that 
Rsp5 promotes RNA export from the nucleus. Notably, Rsp5 seems to globally affect 
the export of nuclear RNAs, as the rsp5 mutant shows a nuclear accumulation of tRNA 
and 60S pre-ribosomal subunits, as well as mRNAs. Although the biochemical 
mechanism remains unknown, it was shown that the nuclear processing of pre-tRNAs 
and pre-rRNAs are defective in the rsp5 mutant (166), suggesting that Rsp5 may affect 
the processing step, which will be reflected as a defect in nuclear export. Interestingly, 
several proteins involved in ribosomal biogenesis and RNA processing were isolated as 
ubiquitinated proteins in a proteomic study (171), and some might be the direct 
substrates of Rsp5, as will be discussed in Chapter 4. A clue to the mechanism of Rsp5-
mediated RNA export is provided in a recent study, where it was suggested that Hpr1, a 
member of the THO/TREX (transcription/export) complex that mediates mRNA 
transcription to nuclear export, is a target of the Rsp5-mediated ubiquitination and 
degradation (80). How the degradation of Hpr1 leads to the export of mRNAs remains 
unclear. 
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Mitochondrial inheritance 
An rsp5 mutant was identified in a genetic screen that showed failed distribution 
of Mod5, a tRNA-modifying enzyme, which normally is localized in the nucleus, 
cytoplasm, and mitochondria (254, 255). Meanwhile, an independent group isolated a 
suppressor of a mdm1 mutant, which displays defect in mitochondrial distribution and 
morphology (64). The suppressor, named smm1 (suppressor of mdp1-dependent 
mitochondrial inheritance defects 1), also map to RSP5. Interestingly, another 
suppressor, smm2, was found to be a mutation in BUL1, whose protein product binds to 
Rsp5 (244), suggesting that the Rsp5 and Bul1 complex are involved in the 
mitochondrial distribution pathway. Importantly, both mdp1 and smm1 mutations were 
mapped within the HECT domain of Rsp5, suggesting that the catalytic activity of the 
E3 ligase was somehow disrupted in those mutants, as is the case in the rsp5-1 mutant 
(227). The smm1 and smm2 mutants displayed defects in mitochondrial distribution, as 
well as cells harboring mutations in both ubc4 and ubc5, the two E2s known to work 
with Rsp5 in yeast (168), further suggesting that the Rsp5-mediated ubiquitinating 
activity is responsible for the mitochondrial distribution. Furthermore, the proper 
distribution of mitochondria has been shown to require K63-linked polyubiquitination, 
consistent with previous roles of Rsp5 in the endocytic pathways (66, 206). The 
specific substrates and molecular mechanism involved in the Rsp5-mediated regulation 
of mitochondrial distribution remain to be determined. 
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Other potential roles  
As mentioned above, the genetic interaction between Rsp5 and Spt3 suggests 
that Rsp5 might have a role in transcriptional regulation. The most convincing data 
implicating Rsp5 in its potential role in the transcription might be that Rsp5 directly 
binds to and ubiquitinates Rpb1, the larges subunit of RNA polymerase II (107). 
Interestingly, a recent proteomic work with the aim of isolating TFIID complex has 
identified Rsp5 and Bul1 along with other transcriptional factors, suggesting that Rsp5 
could be physically forming a complex with transcriptional machinery in the nucleus. 
However, the molecular details as to how Rsp5 might regulate RNA pol II-mediated 
transcription remain uncharacterized. Although it has been shown that Rsp5 induces 
degradation of Rpb1 in DNA-damaged cells (10), whether or not this occurs in 
undamaged cells is unknown.  
Rsp5 has also been implicated in cell wall biogenesis (114). It has been shown 
that an rsp5 mutant is hypersensitive to a cell destabilizing agent calcoflour white 
(CFW), suggesting that the cell wall is defective in the mutant. An electron microscopy 
study revealed an increased chitin level and an aberrant cell wall structure in the mutant, 
suggesting that Rsp5 might be involved in the regulation of cell wall biogenesis and/or 
chitin synthesis. Consistent with this, the temperature sensitive phenotype of the rsp5-1 
mutant was rescued by presence of the osmotic stabilizer sorbitol in the media (120, 
244), further suggesting that the basis for the growth defect of the mutant in high 
temperature might be a defective cell wall. The implications of Ubp2 and K63-
polyubiquitin linkages in this role of Rsp5 will be discussed in more detail in chapter 3. 








Pathways Substrates Chain type/consequence 




Gap1, Fur4, Ste2, Pma1, Put4 
Smf1, Cps1, Phm5, Hxt6/7, Zrt1 
K63, mono?/ endocytosis 





Rpb1, Csr2, Ecm21, Rvs167 
Vps9, Rpa1 
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1.7 Regulation of HECT E3s 
Studies during the past decade showed that HECT E3s are involved in diverse 
physiological pathways from yeast to human. Although the specific substrates of the 
HECT E3s have been relatively well characterized, mechanisms for regulating the 
inherent catalytic ligase activities are only beginning to be explored. Regulation is 
achieved at different steps: phosphorylation, E2 interaction, or by associating with 
regulatory cofactors such as deubiquitinating enzymes. Here I summarize some of the 
recently uncovered mechanisms for regulating HECT E3 ligases. 
Recruitment of E2 
The TGF-β signaling pathway has pleiotropic effects on multiple cellular 
processes, including cellular differentiation and immune responses (135). Regulating 
the pathway is critical for achieving the balanced responses to cellular stimuli, and this 
can be achieved in multiple steps, including the down-regulation of the TGF-β receptor 
protein (135). It has been shown that Smurf2-mediated ubiquitination and degradation 
of TGF-β receptor proteins play a major role in inhibiting the signaling pathway (118). 
This study found that Smurf2, which is normally in the nucleus, is recruited to the 
membrane receptor by Smad7, one of the several Smad-family transducer proteins in 
the signaling pathway. Interestingly, a recent study from the same group have shown 
that the ubiquitinating activity of Smurf2 is significantly stimulated by Smad7 (169). 
This study found that the N-terminal domain of Smad7 binds to both the HECT domain 
and the E2, UbcH7, thereby facilitating interaction between the two proteins. The 
crystal structure of the HECT domain of Smurf2 revealed overall similarity in the 
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conformation the HECT domain to that of the two closely related HECT E3s, E6AP 
and WWP1. Based on this crystal structure, the superimposed view of the E2 binding 
surface between the Smurf2 HECT domain and that of E6AP was analyzed. 
Interestingly, it revealed that the key determinant hydrophobic residues (represented by 
Ile656 and Phe691 in E6AP) in the E2 binding groove within the Smurf2 HECT 
domain were replaced by non-conserved hydrophilic amino acids His547 and Tyr581, 
potentially explaining why Smurf2 has lower inherent E2 binding activity. Interestingly, 
when the key residues in the E2 binding pocket of the Smurf2 HECT domain were 
replaced by those of E6AP, the mutant Smurf2 became constitutively active, 
irrespective of Smad7, as assayed in auto-ubiquitination and the activity of TGF-ß 
receptor activity. 
Therefore, Smad7 appears to have dual effects: it recruits Smurf2 to the 
substrate, the TGF-ß receptor, and it also stimulates the catalytic ubiquitinating activity 
of the ligase by recruiting E2. It is tempting to speculate that Smurf2 might have beeen 
designed to have an inherent sub-optimal level of E2 binding activity such that it can be 
stimulated only by associating with the positive regulator. However, this mechanism is 
not consistent with a recent finding, which demonstrated that the same determinant in 
the E2 is competed by E1 and E3, thus allowing the sequential E1-E2 and E2-E3 
reactions (55). Thus, the increased affinity between the Smurf2 HECT and UbcH7 
potentially means a decreased affinity between E1 and the E2, and a decreased 
ubiquitination. It will be interesting to know if Smad7 hinders the binding between 
UbcH7 and E1. It is not known whether other HECT E3s are regulated in a similar 
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manner. Interestingly, WWP1, a HECT E3 closely related to Smurf1 and Smurf2, have 
also been shown to bind to Smad7 and downregulate TGF-ß receptors (126). It is not 
known whether Smad7 also affects the E2 binding ability of the WWP1 HECT domain. 
Modulating the ability of E2 recruitment as a means of regulating the E3 
activity has been previously reported in a Cullin-based RING E3 ligase (119). It had 
been shown that neddylation of cullin subunits stimulate the ubiquitinating activities of 
the E3 complexes (132). The underlying mechanism for the activation of E3 by 
neddylation has been shown to involve increased recruitment of Ubc4, an E2, to the 
Cul1 subunit of the E3 complex, thereby increasing the ubiquitination of a substrate 
IkBα (119). How the E2 recognizes neddylated Cul1 is unknown. 
Phosphorylation-mediated regulation 
The HECT E3 ligase Itch is involved in numerous cellular processes including 
cell cycle control and immune process (143, 184, 185). The regulatory mechanism for 
Itch represents how activities of HECT E3 ligase can be modulated by different types of 
phsophorylation. It was shown that Itch can be either positively or negatively regulated, 
depending on different kinases and corresponding phosphorylation acceptor sites. It has 
been shown that Itch-mediated c-Jun degradation is dependent on JNK1 kinase, which 
phosphorylates Itch (68). The underlying molecular mechanism is reminiscent of that of 
the Src activation (152). It has been shown that Itch, which is normally kept inactive by 
an inhibitory intra-molecular interaction between the WW domains and the HECT 
domain, becomes activated when three residues (S199, T222, S232) within the so-
called PRR (proline rich region) domain are phosphorylated by JNK (67). The 
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phosphorylation presumably triggers a conformational change that disrupts the 
inhibitory intra-molecular interaction, thus switching the E3 to an active mode. 
Interestingly, it turns out that phosphorylation does not always activate the ligase 
activity, but rather can be inhibitory. It has been shown that Itch can be negatively 
regulated by Fyn kinase-mediated phosphorylation on Y371 residue (242). The 
mechanism for this inhibitory effect seems to be different from the former case, as it 
was shown that the phosphorylation on Y371 reduces the E3’s ability to bind to its 
substrates, although the exact mechanism remains unclear. Thus, the activity of Itch 
seems to be balanced by different signaling pathways that induce the phosphorylation at 
alternate residues. 
Based on the sequence similarity among the HECT E3 members, other HECT 
E3s might be subject to a similar mechanism. Anther HECT E3 ligase, Nedd4, is 
involved in the ubiquitination and endosomal down-regulation of membrane receptor 
proteins, with the best characterized one being the Na (+) channel (ENaC). The Nedd4-
mediated regulation of the receptor activity has been shown to be hormone-dependent, 
and it was shown that the down-regulation of ENaC was significantly inhibited by 
phosphorylation of two serine residues on Nedd4, which is mediated by hormone-
induced kinase (41). The inhibitory effect of phosphorylation on the Nedd4 does not 
seem to inhibit the catalytic activity of the HECT domain, as was the case with Itch, but 
rather it was suggested to affect the ability of Nedd4 to bind to ENaC. Given that the 
phosphorylation sites locate between the WW domains, this study suggests that 
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phosphorylation might alter the conformation of the domains that interact with the PY 
motif of the substrate.   
Deubiquitinating enzymes 
Increasing evidence suggests that deubiquitinating enzymes (DUBs) play 
significant roles in many physiological pathways. It has been shown that some DUBs 
have their own substrate specificity to directly reverse the ubiquitination status of 
substrates (103, 136, 138). Interestingly, recent studies have found that some DUBs are 
physically associated with E3 ligases (17, 89, 120, 127, 220, 239). The purposes of the 
complex formation seem to be different in each case, as some DUBs reverse the 
autoubiquitination of E3 ligases for stabilization and some DUBs inhibit the E3 activity. 
Although many RING E3 ligases seem to be regulated by specific DUBs, the only 
HECT E3 that has been shown to associate with a DUB is Rsp5 (Chapter 2) (120). 
Rsp5, an essential HECT E3 in S. cerevisae, has been shown to associate with Ubp2, 
one of the 16 ubiquitin-specifc proteases (UBPs) in yeast. The functional relationship of 
the Rsp5 and Ubp2 complex will not be described in detail in this section, as it is the 
major subject of this dissertation. It is so far unknown whether Rsp5-homologs in 
mammalian cells (e.g., Nedd4, Smurf1/2) also utilize a similar type of regulation, in 
association with DUBs. 
Other mechanisms 
Mule/ARF-BP1 
ARF is a tumor suppressor that has been shown to stabilize p53 by inhibiting the 
Mdm2 E3 ligase (202). In another study that attempted to characterize the Mdm2-
  47 
independent tumor suppression mechanism of ARF, a HECT E3 ligase was identified to 
be as a major associating factor of ARF (23). Interestingly, the HECT E3, named 
Mule/ARF-BP1, has been shown to ubiquitinate and destabilize p53, (191). Notably, in 
this study, the ability of Mule/ARF-BP1 to ubiquitinate and destabilize p53 was 
strongly inhibited by ARF both in vitro and in vivo, suggesting that Mule/ARF-BP1 is a 
key target of ARF for p53 stabilization. So, how is the Mule/ARF-BP1 E3 activity 
regulated by ARF? Although the answer is not clear, ARF seems to inhibit the catalytic 
activity, not the substrate binding activity, as ARF was found in this study to inhibit 
even the auto-conjugating activity of the E3. It is intriguing to note that ARF was 
shown to directly bind to Mule/ARF-BP1 and the region required for the ARF binding 
in the E3 included the HECT domain. This raises the possibilities that ARF might 
inhibit E2-binding ability of the HECT domain, or it might limit the proper 
conformation of the HECT domain that is necessary for its catalytic activity. Other 
potential regulatory mechanisms may include Bul1 and Bul2-mediated 
polyubiquitination of Gap1, although the precise biochemical reactions remain 
unknown (discussed in “E4” section). 
 
1.8 HECT E3s and clinical implications 
HECT E3s are involved in many physiological processes in human cells and 
implicated in several human diseases, including Angelman syndrome, Liddle syndrome, 
cervical carcinoma, and others. 
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Angelman syndrome 
Angelman Syndrome (AS) is a severe neurological disease with mental 
retardation, seizures, and motor dysfunction in human (34, 155). AS was originally 
found to be associated with chromosomal deletions of human chromosome 15q11-q13 
(155). Although the mutations of other genes in the chromosomal region might 
contribute to the disease, the majority of the mutations were found to be within the 
UBE3A locus, which encodes E6AP (34, 42, 102, 155). Remarkably, only the maternal 
allele of E6AP is expressed in the brain due to tissue-specific maternal imprinting, and 
AS patients lack a functional maternal allele of E6AP in brain (224). Most of the AS-
associated mutations in the E6AP gene were found to involve missense mutations, 
single amino acid insertions/deletions, or frameshift mutations that cause truncation of 
the protein. Importantly, most of these mutations map within, or cause entire truncation 
of the HECT domain, and the structural analysis of the HECT domain of E6AP 
revealed that many of the missense mutations map within the catalytic cleft (102, 155). 
This evidence strongly suggests that the abrogation of the catalytic activity of E6AP 
correlates with AS. However, the specific target(s) of E6AP in the brain associated with 
AS is yet to be identified.  
Liddle syndrome 
Liddle syndrome is a genetic disorder associated with abnormal sodium 
reabsorption in the distal tubule (230). The epithelial Na+ channel (ENaC) plays a 
critical role in the salt and fluid homeostasis in cells and a deregulated opening of the 
channel has been known to cause Liddle syndrome (211, 230). It was shown that the 
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mutations that cause truncation of the cytoplasmic C-terminus or mutations in the 
conserved PY-rich sequences of the beta and gamma subunit of the epithelial sodium 
channel (ENaC) cause the disease. The PY sequences have been shown to interact with 
the WW domains of Nedd4 and the decreased interaction between Nedd4 and ENaC 
has been suggested to be the basis for Liddle syndrome (210, 211, 213, 230). The cells 
with the mutation in the PY motif of ENaC have been shown to display increased 
channel activities, suggesting that decreased ubiquitination of ENaC by Nedd4 is 
associated with the disease. In fact, it has been shown that the deletion of the PY motif 
of ENaC in Liddle syndrome correlates with decreased ubiquitination and increased 
retention of ENaC at the plasmamembrane (196, 210, 212). Consistent with these 
observations, ENaC stability has been shown to be increased by a lysosomal inhibitor, 
suggesting that Nedd4-mediated ubiquitination of ENaC leads to the endocytic 
degradation (211). There have yet been no reports that Liddle syndrome is associated 
with mutations in Nedd4. Although the reason for this is not clear, it is possible that 
more severe phenotypes may be associated with a defective catalytic activity of Nedd4. 
Cervical cancer 
The E6/E6AP-mediated degradation of p53 has been shown to be a critical 
event in the development of cervical carcinoma (106). The “high-risk” human 
papillomaviruses (HPV) such as HPV-16 and HPV-18, are associated with more than 
95% of human cervical carcinomas, while the “low-risk” HPVs such as HPV-6 and 
HPV-11 are associated with benign tumors (256). In the HPV-positive cervical 
carcinomas, generally two HPV-encoded transforming oncoproteins are found, E6 and 
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E7. The oncoproteins are necessary and sufficient for immortalizing human primary 
keratinocytes and inactivate two critical cellular tumor-suppressive proteins, p53 and 
pRB, respectively (100). A study has shown that the mechanism for the E6-mediated 
inactivation of p53 involves the ubiquitin/proteasome pathway (194). It was shown that 
E6 binds to a cellular HECT E3, E6AP, and hijacks the E3 ligase activity of E6AP for 
ubiquitinating p53, which is not a normal target of the E3 ligase (106, 217). siRNA-
mediated depletion of either E6 or E6AP significantly stabilized p53 in the HPV-
positive HeLa cell lines, further suggesting that this is the primary mechanism for 
inactivation of p53 in cervical cancer (122). Although E6 has been shown to target Myc 
for degradation independent of E6AP (77), E6AP has been shown to be required for 
majority of the E6-mediated degradation of cellular proteins other than p53 (69, 71, 130, 
165). Consistent with this, a comprehensive microarray analysis has shown that siRNA-
mediated depletion of E6 or E6AP resulted in nearly identical alterations in total 
transcriptional profiles in three different HPV-positve cell lines, suggesting that E6AP 
mediates a broad range of E6-mediated functions (122). 
Others 
Nedd4-mediated ubiquitination of VP40, a structural protein of Ebola virus, has 
been shown to be an essential process for the viral budding and similar mechanisms 
have been suggested to be used for many other retroviruses (81, 123, 245). TGF-ß 
signaling, which is critical for the broad spectrum of physiological processes including 
cell proliferation and differentiation, has shown to be downregulated by Smurf1, 
Smurf2, and Itch (13, 131, 249). Itch has also been shown to directly ubiquitinate and 
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down-regulate p63 and p73, two p53-related proteins that play important roles in 
cellular development and cell cycle control (184, 185). Additionally, Itch knockout-
mice have been shown to display serious immunological defects, such as hyperplasia of 
lymphoid cells and pulmonary chronic interstitial inflammation (172), suggesting its 
critical role in the immune system. Mule/ARFBP-1 poses as a potential therapeutic 
target for rescuing p53 from degradation to induce apoptosis of tumor cells (22, 23). 
Finally, Herc5, an interferon- induced HECT E3, has been shown to play a crucial role 
in the conjugation of ISG15 (interferon-stimulated gene 15) (39, 236), a ubiquitin-like 
molecule that appears to play roles in anti-viral mechanisms (170, 248). Therefore, 
understanding the regulatory mechanisms of HECT E3s will be important for a broad 
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2.1 Introduction 
               RSP5 is one of five Saccharomyces cerevisiae genes encoding HECT E3s and 
is the only one that is essential under normal growth conditions (227). Lethality of the 
rsp5∆ mutations can be suppressed by the addition of oleic acid to the growth media 
(99). The basis of oleic acid rescue is Rsp5- mediated ubiquitination of the Spt23 
transcription factor, which activates Spt23 by stimulating a proteasome-catalyzed 
processing event (181). Processed Spt23 activates transcription of the OLE1 gene, 
encoding a fatty acid desaturase. Rsp5 has been implicated in other cellular processes, 
most notably in trafficking of plasma membrane proteins. Rsp5 ubiquitinates several 
integral plasma membrane proteins, including Fur4 (66), Gap1 (84), and Ste2 (50), 
targeting them for ubiquitin-mediated endocytosis, and can also direct ubiquitin-
mediated trafficking of proteins from the trans-Golgi network (TGN) to the vacuole 
(86). The latter requires the function of Bul1 and Bul2, two closely related proteins that 
interact with Rsp5 and influence some functions of Rsp5 (4, 113).      
A large family of deubiquitinating enzymes (DUBs) has the capacity to 
influence the fate of ubiquitinated proteins (4). There are at least three broad functions 
for deubiquitinating enzymes: 1) the processing of ubiquitin precursor proteins to 
generate mature ubiquitin, 2) reversing the polyubiquitination of substrate proteins (25, 
139), and 3) facilitating ubiquitin removal at the proteasome, allowing target proteins to 
be translocated into the proteasome (4). DUBs are therefore capable of either promoting 
or antagonizing ubiquitin- and proteasome-dependent processes.  
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While several direct targets and functions of Rsp5 have been identified, the 
basis of regulation of Rsp5 activities is largely unknown. In order to gain insight into 
possible control or regulation of Rsp5 activity, we affinity purified Rsp5 along with 
associated proteins using the tandem affinity purification (TAP) method under 
conditions where interacting or regulatory proteins can be co-purified (177). A 
prominent Rsp5-associated protein was the Ubp2, a member of the UBP family enzyme. 
Rup1, a UBA (ubiquitin-associated) domain-containing protein, was found to mediate 
the Rsp5–Ubp2 interaction, and we present both biochemical and genetic evidence that 
Ubp2 and Rup1 complex antagonizes catalytic activity of Rsp5. Furthermore, I propose 
that the UBA domain of Rup1 has a role in facilitating the catalytic activity of Ubp2. 
Together, our in vitro and in vivo results indicate that at least a fraction of Rsp5 exists 
in a complex with Ubp2, and that the Ubp2/Rup1 complex serves to antagonize, and 
potentially regulate, Rsp5 in vivo. 
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2.2 Materials and methods 
Yeast strains, media, and plasmids 
A list of yeast strains is shown in Table 2.1. Growth media containing oleic acid 
contained 0.5mM oleic acid (Sigma) in the presence of 1% Tergitol. The NTAP-RSP5 
strain (YK001) was generated using FY56 as the parental strain. A C-terminally 
truncated RSP5 mutant fragment was subcloned into pYES2 vector (Invitrogen) deleted 
of the 2u origin, with 500 bp of the RSP5 upstream sequence inserted in place of PGAL1. 
The construct was transformed into FY56 and colonies were selected on Ura- plates. 
Clones that expressed full-length NTAP-Rsp5 and truncated (untagged) Rsp5 protein 
were screened by anti-Rsp5 immunoblotting. Clones were then selected on uracil/5-FOA-
containing plates, and clones that expressed NTAP-Rsp5 as the sole source of Rsp5 were 
isolated (strain YK001). Deletion of the complete UBP2 or RUP1 ORFs (stains YK003, 
YK004, and YK006) was carried out using a PCR-based method with KanMX6 selection 
(144). C-terminal 3xHA tagging of genomic UBP2 in YK001 and BY4741 strains 
(YK002 and YK008, respectively) was carried out similarly, using a HIS3 marker. 
Fulllength ORFs of HA-UBP2, HA-RUP1, HA-UBP3, HA-UBP4, and Flag-SPT23 were 
PCR-amplified from yeast genomic DNA. The active-site mutation of UBP2 (ubp2-
C745S) was generated by site-directed mutagenesis. Other rsp5, ubp2, and rup1 mutants 
were generated by PCR amplification from each full-length ORF. All ORFs were 
subcloned into pYES2 vector for in vitro/in vivo expression or pGEX-6p-1 vector 
(Amersham Biosciences) for bacterial expression of GST fusion proteins.  
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TAP protein purification  
The TAP purification procedure was similar to that described previously (177). An 8 L 
culture of strain YK001 was grown in YPD to an OD600 of 1.2, at 30C. The cell pellet 
was resuspended in NP-40 lysis buffer (0.5% NP-40, 150mM NaCl, 10mM Tris 8.0, 
supplemented with protease inhibitors) and cells were disrupted with a bead beater. The 
extract was cleared by centrifugation at 31000 g for 15 min at 4C. IgG Sepharose 
(Amersham Biosciences) was added and incubated with mixing for 4 h at 4C. The beads 
were washed in NP-40 lysis buffer, followed by TEV cleavage buffer (0.1% NP-40, 
150mM NaCl, 10mM Tris pH 8.0, 0.5mM EDTA, 1.0mM DTT), and TEV protease was 
added and incubated at room temperature for 2 h. The supernatant was diluted with 
calmodulin binding buffer (150mM NaCl, 10mM Tris pH 8.0, 1mM magnesium acetate, 
1mM imidazole, 2mM CaCl2, 10mM β-mercaptoethanol) and Calmodulin Sepharose 
(Amersham Biosciences) was added and incubated for 1.5 h at 41C. After washing, 
bound proteins were eluted in buffer containing 150mM NaCl, 10mM Tris pH 8.0, 0.02% 
NP-40, 1mM Mg2+ acetate, 1mM imidazole, 20mM EGTA, 10mM DTT). The final 
eluate was TCA-precipitated, resuspended in 1X SDS–PAGE loading buffer, and loaded 
on a 4–15% gradient SDS–PAGE gel. Gels were stained with either silver or Coomassie 
blue. Bands were excised from a Coomassie blue-stained gel and subjected to in-gel 
tryptic digest. The fragmented peptides were analyzed by LC/MS. The peptide sequence 
information was used to search for protein identification using the Mascot (Matrix 
Sciences) search engine. For confirmation of protein interactions, small-scale TAP 
purifications were performed. Cell extracts from each TAP strain was subject to IgG 
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Sepharose purification, with release of bound proteins by SDS–PAGE loading buffer. 
Proteins were separated by SDS–PAGE and immunoblotting was performed using the 
indicated antibodies.  
 
In vitro protein interaction assays  
GST fusion proteins were expressed from the pGEX-6p-1 vector in Escherichia coli 
DH5a and purified by standard methods on glutathione Sepharose. 35S-labeled proteins 
were synthesized in vitro using a coupled transcription–translation rabbit reticulocyte 
system (Promega). Yeast cell extracts for binding assays were prepared by growing cells 
in YPD until mid-log phase, resuspending the pellets in NP-40 lysis buffer, and lysing the 
cells with a bead beater. Cell extracts were cleared by centrifugation at 27,000 g for 10 
min. Either 50 mg of whole-cell extracts was used for each binding assay or equal 
volumes of fractions from a DEAE ion exchange column. Complex formation using 
purified proteins (Rsp5, Ubp2, and Rup1 or Rup1∆UBA) was performed using GST 
fusions. Ubp2, Rup1, and Rup1∆UBA were cleaved from GST by PreScission protease 
(Amersham Biosciences). Binding reactions were performed using GST-Rsp5 on 
glutathione beads and each of the other free proteins for 2 h at 4C. Total protein was 
recovered from the washed beads by elution with SDS–PAGE loading buffer. For 
mapping of domains that mediate the ternary complex, bacterially expressed and purified 
GST-Rsp5 proteins (227) and in vitro translated wild-type Ubp2 were used, along with 
purified Rup1 protein from bacteria. To map regions of Rsp5 that are required for binding 
to Rup1, bacterially purified GST-Rup1 and in vitro translated Rsp5 proteins were used. 
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To map the regions of Ubp2 that are required for binding to Rsp5 or Rup1, purified GST-
Rsp5, Rup1, and in vitro-translated Ubp2 proteins were used. Binding reactions were 
performed as described above.  
 
In vitro ubiquitination and deubiquitination assays  
In vitro ubiquitination/deubiquitination assays were performed in the presence of 10mM 
Tris pH 7.5, 50mM NaCl, 5mM ATP, 5mM MgCl2, 0.1mM DTT, and 50 ug/ml ubiquitin 
(Sigma). Bacterially expressed wild-type Rsp5, Rsp5-C777A, Ubp2, Rup1, Rup1∆UBA, 
and yeast E2 (Ubc1) were purified on glutathione Sepharose and cut with PreScission 
protease (Amersham Biosciences). WBP2, p53, hScribble, and Spt23 were in vitro 
translated in the presence of 35S-methionine. The translation reaction (3–4 ul) was used 
for each ubiquitination/deubiquitination reaction. The ubiquitination reactions were 
carried out for 30 min at room temperature, followed by additional 30 min incubation in 
the presence or absence of Rup1 and/or Ubp2. The reactions were performed as described 
above and stopped by addition of 1X SDS–PAGE loading buffer and products were 
analyzed by SDS–PAGE and autoradiography.  
 
Gel Filtration analysis 
30ml of TAP-UBP2 (YK005) strain was grown in YPD media until O.D of 1.5 and the 
cell extracts were prepared in a lysis buffer (0.1% NP40, 20mM NaCl, 10mM Tris pH. 
7.0). The cell extracts were subject to 30ul of DEAE sepahrose (Amersham Biosciences) 
and bound for 20 minutes and washed with the same buffer 3 times before eluted with 
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500mM NaCl. The high salt eluate was subject to SephacrylTM High resolution S300 
size exclusion column (Amersham Biosciences) and equal amounts were collected 
using high salt elution buffer (1M NaCl, 20mM Tris pH 7.0). Equal amount of each 
fraction was analyzed by 10% SDS-PAGE followed by western blot analysis using anti-




















Strain Genotype References 
FY56 MATα his4-912δR5 lys2-128δ ura3-52 (107) 
YK001 MATα NTAP-RSP5 his4-912δR5 lys2-128δ ura3-52 (120) 
YK002 
MATα NTAP-RSP5 ubp2∆:: UBP2-3XHA:: KanMX6 his4-912δR5 lys2-128δ 
ura3-52 
(120) 
YK003 MATα rsp5-1 ubp2∆::KanMX6  his4912δR5 lys2-128δ ura3-52 (120) 
YK004 MATα rsp5-1 rup1∆::KanMX6  his4912δR5 lys2-128δ ura3-52 (120) 
FW1808 MATα rsp5-1 his4912δR5 lys2-128δ ura3-52 (107) 
YK003 MATα rsp5-1ubp2::KANMX6 his4912δR5 lys2-128δ ura3-52 (120) 
YK004 MATα rsp5-1rup1::KANMX6 his4912δR5 lys2-128δ ura3-52 (120) 
BY4741 MATa his3 leu2 met15 ura3 Open Biosystems 
YK005 MATa TAP-UBP2 his3 leu2 met15 ura3 Open Biosystems 
YK006 MATa TAP-UBP2::HIS3  rup1::KanMX6  his3 leu2 met15 ura3 (120) 
YK007 MATa TAP-RUP1::HIS3  his3 leu2 met15 ura3 Open Biosystems 
YK008 MATa ubp2∆::UBP2::3XHA::KanMX6 his3 leu2 met15 ura3 (120) 
YK009 MATa ubp2∆::KanMX6 his3 leu2 met15 ura3 Open Biosystems 
YK010 MATa rup1∆::KanMX6 his3 leu2 met15 ura3 Open Biosystems 
YK011 MATa TAP-UBP3 his3 leu2 met15 ura3 Open Biosystems 
YK012 MATa TAP-UBP4 his3 leu2 met15 ura3 Open Biosystems 
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2.3 Results 
Purification of NTAP-Rsp5 and associated proteins  
To identify proteins associated with Rsp5, I utilized a TAP-purification method. 
The advantage of the TAP method over other conventional methods such as yeast two 
hybrid screen is that both indirectly and directly interacting proteins can be purified 
under physiologically relevant conditions. Additionally, the TAP method can indicate 
the approximate stoichiometry of proteins in a given complex. A yeast strain was 
generated in which the NTAP (N-terminal TAP) epitope was integrated at the 5’ end of 
the chromosomal RSP5 ORF, so that expression of NTAP-Rsp5 was directed by the 
natural RSP5 promoter (Figure 2.1A; see material and methods). The NTAP-RSP5 
strain was fully viable at both 30C and 37C, and the expression level of NTAP-Rsp5 
was similar to that of endogenous Rsp5 in the parental strain (Figure 2.1B). NTAP-
Rsp5 protein was purified from extract of an 8 L culture grown to mid-log phase. The 
first affinity purification step was performed on IgG Sepharose, with release of NTAP-
Rsp5 by cleavage with TEV protease. The second affinity step was performed on 
calmodulin agarose with EGTA elution. The final eluate was concentrated and an 
aliquot was analyzed by SDS–PAGE and silver staining (Figure 2.1C). Several 
prominent bands in addition to Rsp5 were evident, and several were gel-isolated and 
identified by liquid chromatographic mass spectrometric analysis (LC/ MS). The major 
bands less than 45 kDa were all breakdown products of NTAP-Rsp5, and the band at 
approximately 95 kDa was full-length Rsp5 (containing the residual CBP epitope). 
 










































































Figure 2.1 TAP-Rsp5 purification. (A) Shematic diagram for generating NTAP-RSP5 
strain. The scheme exploited two homologus recombination events, with first positive 
selection on Ura- plates (1) followed by second negative selection on 5FOA plates. (B) 
Confirmation for expression of NTA-Rsp5 using anti-Rsp5 and anti-TAP (peroxidase anti 
peroxidase). (C) Purification of NTAP-Rsp5 and associated proteins from extract of an 8 
l culture (YK001). The final eluate was concentrated and separated by SDS–PAGE and 
silver stained. The positions and identities of bands identified by LC/MS are indicated; 
Rsp5* indicates breakdown products of NTAP-Rsp5. Molecular weight markers (kDa) 
are indicated. 
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Ubp2
1272 a.a.
The three prominent bands that migrated with apparent molecular weights 
greater than Rsp5 were identified as Bul1, Ubp2, and Chc1. Bul1 is a previously 
identified Rsp5-interacting protein (243, 244). Chc1 is clathrin heavy chain and it has 
been previously suggested that Chc1 might interact with Rsp5 in a Pan1-dependent 
manner (231). We were intrigued by the fact that Ubp2 co-purified with Rsp5, since 
these enzymes have opposing biochemical activities. Ubp2 is one of the 16 ubiquitin 
specific proteases (UBPs) and sequence analysis revealed that it has a three short 
stretches of sequences that are conserved among UBPs and UCHs (ubiquitin C-terminal 
hydrolases; shown as ‘UCH’ in the figure) at the C-terminal region of the protein, and 
large N-terminal extension with no distinctive sequence homology (Figure 2.2). One of 
the three conserved regions contains a putative Cys box domain with highly conserved 
sequences surrounding a cystein residue, suggesting that the cystein residue (C745 in 








Figure 2.2 Ubp2 has a Cys box, one of the conserved signatures of UBPs. 
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The interaction between Rsp5 and Ubp2 was confirmed by integrating an HA 
epitope at the 3’ end of the chromosomal Ubp2 ORF in both the NTAP-RSP5 and 
parental RSP5 strains. Extracts from these strains were subject to IgG Sepharose affinity 
chromatography, and bound proteins were analyzed by SDS–PAGE and immunoblotting 
with anti-HA antibody. Figure 2.3A shows that HA-Ubp2 specifically co-purified with 
NTAP-Rsp5, not with IgG sepharose in the control lane (lane 6). In addition, a strain 
expressing CTAP-Ubp2 (C-terminal TAP epitope) was used to demonstrate that 
endogenous Rsp5 protein co-purified with CTAP-Ubp2 (Figure 2.3B), not with IgG 
sepharose. These results strongly suggest that at least a fraction of the cellular pools of 













  65 
A.
NTAP-Rsp5:      - +     - - +     -
HA-Ubp2:      +      +     -
Extracts             IgG Purif.
CTAP-Ubp2:      +       - +       -
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Figure 2.3 Confirmation of the Rsp5-Ubp2 interaction. (A) Extracts were prepared from 
YK002 (NTAP-RSP5, HA-UBP2), YK008 (RSP5, HA-UBP2), and BY4741 (RSP5, 
UBP2). Proteins were affinity selected on IgG Sepharose and bound proteins were 
released with SDS–PAGE loading buffer. Total extracts (lanes 1–3) and eluates (lanes 
4–6) were analyzed by SDS–PAGE and immunoblotted with anti-HA antibody. (B) 
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Extracts were prepared from YK005 (TAP-UBP2) and BY4741 (RSP5, UBP2) and 
proteins were affinity selected on IgG Sepharose. Total extracts (lanes 1 and 2) and 




The Rsp5–Ubp2 interaction is mediated by Rup1 
  To determine whether Rsp5 and Ubp2 bound to each other directly in vitro, I 
performed binding assays with bacterially expressed GST-Rsp5 and in vitro-translated 
35S-labeld Ubp2. GST-Rsp5 is enzymatically active and has been shown to bind to 
several Rsp5-interacting proteins in vitro (107, 189, 199), yet stable interaction was not 
detected with the labeld Ubp2 (Figure 2.4A, lane 1). The addition of total yeast cell 
extract or a high-salt DEAE fraction from cell extract stimulated the binding of Ubp2 to 
Rsp5 (Figure 2.4A, lanes 2 and 5), suggesting that an additional factor(s) might mediate 
the interaction. GST-E6AP, a human HECT E3, did not bind to Ubp2 in the absence or 
presence of yeast cell extract. To identify the potential mediator of Rsp5–Ubp2 binding, 
I performed a large-scale purification of CTAP-tagged Ubp2 (C-terminally TAP tagged) 
and identified copurifying proteins. As expected, Rsp5 was identified in the LC/MS 
analysis of CTAP-Ubp2-associated proteins (Figure 2.4B). A prominent Ubp2-
associated protein with an apparent molecular weight of approximately 85 kDa was 
identified by mass spectrometry as Rup1 (YOR138C; calculated molecular weight 75 
kDa). Rup1 has an N-terminal UBA domain (amino acids 1–41) but no other 
discernible functional domains. UBA domains of some proteins have been shown to 
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bind to polyubiquitin chains (24, 179, 233). RUP1 has been reported to be a 
nonessential gene Saccharomyces Genome Database, www.yeastgenome.org), a result 
that we confirmed (below). In a separate experiment, I performed a large-scale CTAP-
Rup1 purification and Ubp2 was purified as nearly one to one stoichiometric amount in 
the purification by LC/MS analysis (not shown). Rsp5 was also found in the analysis. 
To confirm the Ubp2–Rup1 interaction, HA-Rup1 was expressed in the CTAP-
Ubp2 strain and was shown to copurify with CTAP-Ubp2 (Figure 2.4C). HA-Rup1 also 
co-purified with Rsp5 when expressed in the NTAP-RSP5 strain (Figure 2.4C). Rup1 
was not identified in the NTAP-Rsp5 purification (Figure 2.1C), due to the fact that the 
region of the gel where Rup1 migrated was not analyzed in detail because of the large 
amount of breakdown products of NTAP-Rsp5 protein that migrated in the 80–90 kDa 
range. To determine whether Rup1 was responsible for mediating the Rsp5–Ubp2 
interaction, a rup1∆ mutation was created in the CTAP-UBP2 strain. CTAP-Ubp2 was 
purified from this strain, and immunoblotting indicated that the degree of Ubp2–Rps5 
association was greatly decreased relative to the equivalent CTAP-UBP2/RUP1 strain 
(Figure 2.5A, compare lanes 1 and 4). Figure 2.5A also shows that Rsp5 did not 
significantly co-purify with two other TAP-tagged Ubp proteins, Ubp3 or Ubp4, 
strongly suggesting that the interaction of Rsp5 with Ubp enzymes is specific for Ubp2. 
In addition, RUP1 WT yeast cell extract stimulated the binding of in vitro translated 
Ubp2 to GST-Rsp5, while cell extract from an rup1∆ strain did not (Figure 5B). 
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Figure 2.4 A cellular factor mediates the association of Rsp5 and Ubp2. (A) In vitro-
translated 35S-labelled Ubp2 was incubated with GST-Rsp5 or GST-E6AP immobilized 
on glutathione Sepharose, in the absence (−lanes) or presence of cell extracts (Ex.; lanes 
2 and 7) or fractionated extracts (lanes 3–5) from the ubp2  strain. Bound Ubp2 was 
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detected by SDS–PAGE and autoradiography. DEAE high-salt fractions were either 150 
or 500 mM NaCl eluates; FT represents the flow-through fraction. Input (lane 8) shows 
50% of translation mixture used in the binding assays. (B) TAP purification of Ubp2-
associating proteins. Proteins from YK005 (CTAP-UBP2) were affinity selected on IgG 
Sepharose followed by elution and cleavage with TEV protease. The eluate (lane 2) was 
separated on 4–15% gradient gel and stained with Coomassie blue. A parallel purification 
was performed using the control BY4741 strain (lane 1). Arrows indicate the position of 
Ubp2, Rsp5, and Rup1 proteins, as identified by LC/MS. Molecular weight markers (kDa) 
are indicated. (C) HA-Rup1 binds to both NTAP-Rsp5 and CTAP-Ubp2. HA-Rup1 was 
expressed from a galactose-inducible promoter plasmid in strains YK001 (NTAP-RSP5), 
YK005 (CTAP-UBP2), and BY4741 (control, lane 1, not expressing any TAP-tagged 
protein). Extracts were prepared and TAP proteins purified on IgG Sepharose. Eluates 
(lanes 1–3) were analyzed by SDS–PAGE and immunoblotting with anti-HA antibody. 
Lane 4 shows HA-Rup1 in total lysate from BY4741. Detection of NTAP-Rsp5 and 
CTAP-Ubp2 (lanes 2 and 3, respectively) was a result of anti-mouse IgG secondary 
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Figure 2.5 Rup1 is necessary for the association of Rsp5 and Ubp2 both in vitro and in 
vivo. (A) Cell extracts were prepared from strains expressing the indicated CTAP-
tagged Ubp proteins in either an RUP1 or rup1  background. Proteins were affinity 
selected on IgG Sepharose and eluates were analyzed by SDS–PAGE and 
immunblotting with anti-Rsp5 antibody. (B) 35S-labeled Ubp2 was assayed for binding 
to GST-Rsp5 (as in Figure 4A) in the presence of cell extract from either the rup1  
strain (lane 1) or an RUP1 wild-type strain (lane 2). Lane 3 shows 50% of the input 
amount of Ubp2 used in the binding reactions. 
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To determine if Rup1 was sufficient for mediating the association in a purified 
system, Rsp5, Ubp2, and Rup1 were individually expressed as GST fusion proteins in 
bacteria. The proteins were purified and the GST moieties were removed from Ubp2 and 
Rup1 by site-specific proteolysis. GST-Rsp5, on glutathione sepharose, did not stably 
bind to purified Ubp2 (Figure 2.6A, lane 1). The addition of purified Rup1 stimulated 
Ubp2 binding (lane 4), indicating that Rup1 is sufficient for mediating the Rsp5-Ubp2 
interaction. Furthermore, GST-Rsp5 bound directly to Rup1 in the absence of Ubp2, 
indicating that the interaction between these two proteins is direct. These experiments 
were also performed with a truncated form of Rup1, lacking the N-terminal UBA domain 
(Rup1-∆UBA; lacking amino acids 2–40). Rup1-∆UBA protein bound to Rsp5 similarly 
to full-length Rup1 and also mediated the interaction with Ubp2. Figure 2.6B confirms 
that GST-Rup1 binds to in vitro-translated Rsp5 in the absence of Ubp2, as well as to in 
vitro translated Ubp2 in the absence of Rsp5. GST-E6AP did not interact with either 
Rup1, Ubp2, or Rsp5. Together, the in vitro binding results indicate that Rup1 can 
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Figure 2.6 Rup1 mediates the interaction between Rsp5 and Ubp2. (A) Purified Ubp2, 
Rup1, and Rup1 UBA proteins were used in GST-Rsp5 pull-down assays. A 100% of 
input amounts of each protein is shown in lanes 6–9. Bound proteins were analyzed by 
SDS–PAGE and Coomassie blue staining. (B) Rup1, Rsp5, and Ubp2 were 35S-labeled 
by in vitro translation and assayed for binding to purified GST-Rsp5, E6AP, or Rup1. 
Inputs (lanes 7–9) show 50% of the translation mixture used in the binding assays. 
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Domains that mediate formation of the ternary complex  
To define the domains of Rsp5 necessary for binding to Rup1 and Ubp2, a series 
of N- and C-terminally truncated Rsp5 proteins were expressed either as GST fusion 
proteins or as in vitro translated proteins (Rsp5 proteins A–I; Figure 2.7A). The smallest 
region of Rsp5 that is capable of interacting with GST-Rup1 required both the C2 domain 
and the first WW domain (Rsp5-H; Figure 2.7B). Figure 2.7C shows binding of in vitro 
translated Ubp2 to GST-Rsp5 proteins A–E in the presence of purified Rup1 protein. 
Full-length GST-Rsp5 bound to Ubp2, but deletion of either the HECT domain or the 
region spanning the C2 domain abrogated Ubp2 binding. This is the only case where the 
HECT domain has been shown to be required for a protein-protein interaction, except for 
E2, although the HECT domain itself was not sufficient for interacting with Ubp2. 
Therefore, determinants for Ubp2 interaction span a large region of Rsp5 and extend 
beyond what is sufficient for binding to Rup1, suggesting that there might be a direct 
contact between Rsp5 and Ubp2, potentially in the HECT domain. In addition, Rsp5 
deleted of the last six amino acids (Rsp5-E), which disrupts ubiquitination activity (189), 
as well as full-length Rsp5 containing the active-site Cys (C777) to Ala mutation (not 
shown), bound to Ubp2 similarly to wild-type Rsp5, indicating that catalytic activity of 
Rsp5 is not necessary for Ubp2 association. Similarly, Ubp2 with active-site Cys (C745) 
mutated to Ser equally bound to GST-Rsp5 compared to wild type Ubp2 (not shown), 
suggesting that the catalytic activity of Ubp2 is not required for the binding, either.  
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Figure 2.7 Domains of Rsp5 required for binding to Rup1 and Ubp2. (A) Schematic of 
Rsp5 truncation mutants used in binding assays. (B) Binding of GST-Rup1 to Rsp5 
proteins. 35S-labeled in vitro-translated Rsp5 proteins were incubated with GST-Rup1 
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and bound proteins were resolved by SDS–PAGE and visualized by autoradiography. 
Input amounts (left panel) represent 50% of the translations used in the binding reaction 
(right panel). (C) Binding of GST-Rsp5 proteins to Ubp2. Purified GST fusion Rsp5 
proteins, on glutathione Sepharose, were incubated with 35S-labeled in vitro-translated 
Ubp2 in the presence (lanes 2–6) or absence (lane 1) of purified Rup1, and bound 
proteins were resolved by SDS–PAGE and visualized by autoradiography. Input (lane 7) 
indicates 50% of translation used in the binding reaction. 
 
 
A series of N-terminally and C-terminally truncated Ubp2 proteins (Ubp2 
proteins A–E; Figure 2.8A) were expressed by in vitro translation and assayed for GST-
Rup1 binding (Figure 2.8B) and GST-Rsp5 binding in the presence of Rup1 (Figure 
2.8C). The C-terminal 322 residues of Ubp2 (Ubp2-E) were sufficient to mediate direct 
binding to Rup1, and the same region was sufficient for Rup1-mediated Rsp5 
association. Together with the results shown in Figure 2.6A, I conclude that (1) the 
UBA domain of Rup1 is not necessary for formation of the ternary complex, (2) the C-
terminal 322 residues of Ubp2 are sufficient for interaction with both Rup1 and the 
Rsp5/Rup1 complex, (3) the region spanning the C2 domain and first WW domain of 
Rsp5 are sufficient for interaction with Rup1, and (4) in addition to determinants 
required for Rup1 binding, determinants within the HECT domain are also necessary 
for stable association of Rsp5 with Ubp2.  
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Figure 2.8 Domains of Ubp2 required for binding to Rsp5 and Rup1. (A) Schematic 
Ubp2 mutants used in binding assays. (B) Binding of GST-Rup1 to Ubp2 proteins. 35S-
labeled in vitro-translated Ubp2 proteins were incubated with GST-Rup1 and bound 
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proteins were resolved by SDS–PAGE and visualized by autoradiography. Input amounts 
(left panel) represent 50% of the translations used in the binding reaction (right panel). * 
indicates predicted size of primary translation product for Ubp2-D. (C) Binding of GST-
Rsp5 to Ubp2, in the presence of Rup1. 35S-labeled in vitro-translated Ubp2 proteins 
were incubated with GST-Rsp5 in the presence of added Rup1 protein, and bound 
proteins were resolved by SDS–PAGE and visualized by autoradiography. Input amounts 
(left panel) represent 50% of the translations used in the binding reaction (right panel). 
 
 
Genetic interactions between Rsp5, Ubp2, and Rup1  
Since Rsp5 and Ubp2 catalyze opposing reactions, we hypothesized that Ubp2 
might exist in a complex with Rsp5 in order to antagonize and potentially regulate Rsp5 
activity. To test this hypothesis, I overexpressed Ubp2 under control of a galactose-
inducible promoter in a wild-type RSP5 strain (FY56) and in the rsp5-1 mutant 
(FW1808). The premise was that overexpression of Ubp2 would cause a reduction in 
effective Rsp5 activity and therefore mimic rsp5 loss-of-function mutations. The rsp5-1 
mutation is located within the HECT domain (L733S) and impairs enzymatic activity of 
the purified protein in vitro (227) The rsp5-1 strain (FW1808) grows normally at 30C, 
but undergoes a rapid non-cell-cycle-specific growth arrest at 37C. A control vector 
(empty pYES2) and pYES2 expressing wild-type Ubp2 or the active-site mutant of 
Ubp2 (C745S) were introduced into the rsp5-1 strain and a wild-type RSP5 strain 
(FY56). A slight growth defect was seen in the RSP5 background when expression of 
Ubp2 was induced by galactose, and this effect was not seen with the C745S mutant 
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(Figure 2.9A). This effect was greatly enhanced in the rsp5-1 background, suggesting 
that Ubp2 antagonizes Rsp5 activity. While overexpression of Ubp3 or Ubp4 resulted 
in a slight growth inhibition of the rsp5-1 strain, a similar effect was seen in the RSP5 
strain (Figure 2.9B), suggesting that this is unlikely to be related to effects on Rsp5 
activity. Overexpression of HA-RUP1 did not inhibit growth of either the RSP5 or rsp5-
1 strains at 30C (not shown); however, a growth defect was seen upon overexpression 
of HA-RUP1 at 34C in the rsp5-1 strain (Figure 2.9C). Overexpression of HA-RUP1 
deleted of the UBA domain did not elicit a growth defect, suggesting that, while the 
UBA domain is not necessary for stable ternary complex formation in vitro, this domain 
is important for mediating the antagonistic effect of Ubp2 on Rsp5 in vivo. Anti-HA 
immunoblotting showed that the full-length and ∆UBA proteins were expressed at the 
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Figure 2.9 Genetic interactions between Rsp5, Ubp2, and Rup1. Overexpression of Ubp2 
or Rup1 inhibits growth of the rsp5-1 mutant. (A) FY56 (RSP5) and FW1808 (rsp5-1) 
were transformed with pYES2 (vector), pYES-UBP2, or pYES-ubp2 C745S plasmids. 
The transformants were serially diluted (10-fold at each step) and plated onto either 
dextrose (Dex.) or galactose (Gal.) media and grown for 2 and 3 days, respectively, at 
30°C. (B) FY56 (RSP5) and FW1808 (rsp5-1) were transformed with empty vector, or 
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pYES-UBP2, UBP3, or UBP4 plasmids and serially diluted on galactose media and 
grown for 3 days at 30°C. (C) FW1808 (rsp5-1) was transformed with empty vector, 
pYES-RUP1, and pYes-rup1 UBA plasmids and serial dilutions were plated onto either 




I further predicted that if UBP2 and RUP1 cooperate to antagonize RSP5 activity, 
then gene deletion of either UBP2 or RUP1 might rescue the temperature sensitivity of 
the rsp5-1 mutant by effectively increasing Rsp5 activity. As shown in Figure 2.10, both 
the ubp2∆ and rup1∆ mutations partially rescued the temperature sensitivity of the rsp5-1 
mutation at 37C, further suggesting that Ubp2/Rup1 complex is functionally antagonistic 
to Rsp5. The degree of rescue was more prominent in the case of ubp2∆ compared to 
rup1∆, possibly due to the week interaction between Rsp5 and Ubp2 in the absence of 

































Figure 2.10 Genetic interactions: ubp2  or rup1  mutations partially rescue the 
temperature sensitivity phenotype of the rsp5-1 mutant. RSP5 (FY56), rsp5-1 
(FW1808), rsp5-1, ubp2  (YK003), and rsp5-1, rup1  (YK004) strains were serially 




An essential function of Rsp5 at 30C has been shown to be ubiquitin-mediated 
activation of the Spt23 and Mga2 transcription factors, which are necessary for OLE1 
gene expression and biosynthesis of oleic acid. I therefore tested whether the growth 
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defect due to Ubp2 overexpression was related to a deficiency in oleic acid biosynthesis 
by attempting to suppress the UBP2 overexpression phenotype with exogenous oleic acid. 
Growth was weakly rescued by oleic acid (Figure 2.11A), suggesting that Ubp2 functions, 
in part, to antagonize the ability of Rsp5 to activate the Spt23 and/or Mga2 transcription 
factors. However, the fact that rescue by oleic acid was weak indicates that the Rsp5–
Ubp2 enzyme pair affects more than a single aspect of fitness as 30C. The genetic 
interactions described above indicate that elevated Ubp2 activity, relative to Rsp5 activity, 
mimics loss of function of Rsp5. I was interested in whether the opposite scenario - 
elevated Rsp5 activity relative to Ubp2 - resulted in a discernible phenotype. While S. 
cerevisiae requires oleic acid for survival, an excess of oleic acid, through 
hyperactivation of OLE1 gene transcription, for example, is also toxic (99, 214). 
Consistent with this, overexpression of Spt23 from a galactose-inducible promoter 
resulted in a strong growth defect in a wild-type RSP5 background (Figure 2.11B). 
Because Rsp5 is required for ubiquitin-mediated activation of Spt23, we predicted that 
the growth defect due to overexpression of Spt23 would be diminished in the rsp5-1 
background, and this was indeed the case (Figure 2.11B). Furthermore, Spt23 
overexpression in the ubp2∆ mutant enhanced the toxicity due to Spt23 overexpression in 
the RSP5 background. These results indicate that elevated Rsp5 activity relative to Ubp2 
activity results in hypersensitivity to the effects of Spt23 overexpression and further 
substantiates an antagonistic relationship between Rsp5 and Ubp2.  
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Figure 2.11 Genetic interactions: genetic link between Ubp2 and the OLE pathway (A) 
Exogenous oleic acid partially suppresses the growth inhibition due to Ubp2 
overexpression. FW1808 (rsp5-1) transformed with pYES2 (vector), pYES-UBP2 (in 
duplicate), or pYES-ubp2 C745S was streaked onto galactose-containing media, in the 
absence or presence of added oleic acid, and grown at 30°C for 4 days. (B) Toxicity due 
to Spt23 overexpression is suppressed by rsp5-1 and enhanced by ubp2 . Upper panel: 
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The pYES-SPT23 plasmid was transformed into FY56 (RSP5) or FW1808 (rsp5-1) and 
plated on galactose- or dextrose-containing media. Lower panel: The empty pYES 
vector or pYES-SPT23 plasmid was transformed into either UBP2, ubp2 , or ubp5  






Temperature sensitivity of the rsp5-1 mutant was rescued by the addition of 1M 
sorbitol to the growth media (Figure 12A), as previously shown for the rsp5-101 mutant 
(244), suggesting that ubiquitination of one or more targets of Rsp5 is important for 
osmotic stability. I therefore predicted that the Ubp2 overexpression phenotype in the 
rsp5-1 background at 30C might be due, in part, to osmotic instability. This was 
confirmed, as shown in Figure 2.12B. The suppression of the UBP2 overexpression 
phenotype by 1M sorbitol was significantly more robust than rescue by oleic acid, 
suggesting that the predominant defect due to overexpression of Ubp2 is related to 
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Figure 2.12 Genetic interactions: the UBP2 overexpression phenotype in the rsp5-1 
mutant is rescued by 1 M sorbitol. (A) RSP5 (FY56) and rsp5-1 (FW1808) strains were 
plated on dextrose-containing media at 37°C, with or without 1 M sorbitol. (B) The 
indicated FW1808 transformants were serially diluted and plated onto galactose-
containing media at 30°C, with or without the addition of 1 M sorbitol to the media. 
The – sorbitol plate was grown for 3 days, and the + sorbitol plate was grown for 4 days. 
A. 
B. 
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Ubp2 reverses Rsp5-catalyzed ubiquitination in vitro  
To test whether Ubp2 directly opposes Rsp5 activity in vitro, I performed in vitro 
ubiquitination assays with two substrates of Rsp5, Spt23 and WBP2. Spt23 is a 
biologically relevant Rsp5 substrate, while WBP2 is a human protein that is recognized 
by Rsp5 and Nedd4, a human homolog of Rsp5 (189). These assays were performed with 
yeast Ubc1 as the E2 enzyme, which has been shown to function with Rsp5 in vivo (49), 
and mammalian UbcH7 as well as Arabidopsis Ubc8 (not shown). As shown in Figure 
13A, Rsp5 efficiently catalyzed polyubiquitination of in vitro-translated Spt23 and WBP2. 
Interesitngly, Ubp2 efficiently deconjugated the pre-ubiquitinated substrates when it was 
added to the reaction 30 minutes after the ubiquitination reaction. The catalytic active site 
mutant of Ubp2 (Ubp2C745S) did not have any effect, as expected. Notably, Rup1, 
which is required for the interaction between Rsp5 and Ubp2, was not required for the 
deubiquitinating activity (Figure 2.13A lane 3s in both panels). However, if the 
concentration of Ubp2 is limited, the deubiquitinating activity was partially dependent on 
the presence of Rup1 (Figure 2.13B). The addition of Rup1, 30 min after initiation of the 
ubiquitination reaction, did not affect ubiquitination of Spt23 or WBP2. The addition of 
both Rup1 and Ubp2 resulted in enhanced deubiquitination. Therefore, Ubp2 can reverse 
Rsp5-catalyzed ubiquitination in vitro, and Rup1, while not absolutely required, 
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Rsp5p:       +     - +    +    +    +    +          +     - +    +    +     +    +
Ubp2p:        - - - +    + ++  ++   - - - +    +    ++  ++
Rup1p:        - - +     - +     - +          - - +    - +      - +
Spt23
WBP2
1     2      3      4     5     6      7           1     2      3      4      5      6     7
B.
A.
Ubp2:     - - WT   CS - - WT   CS
Rsp5:   CA    WT    WT   WT CA   WT WT   WT
















Figure 2.13 Ubp2 antagonizes Rsp5-catalyzed ubiquitination in vitro. Rsp5 
ubiquitination assay utilized 35S-labeled in vitro-translated Spt23 (left) and WBP2 
(right). Each reaction contained purified E1, E2 (Ubc1), Ub, ATP in the absence or 
presence of Rsp5. At 30 minutes after initiating the ubiquitination reaction, Rup1 and/or 
Ubp2 (two different concentrations) were added, followed by additional 30 minutes 
incubation. The reactions were stopped by adding 1X SDS-loading buffer and analyzed 
by 8% SDS-PAGE and visualized by autoradiography. 
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Figure 2.14 shows that, at the similar range of lower concentrations of Ubp2 as in 
figure 2.13B, Rup1 enhanced the activity of Ubp2 against free polyubiquitin chains.  
Interestingly, this effect was dependent on the UBA domain of Rup1, suggesting that the 
UBA domain plays a role in antagonizing Rsp5 function beyond simply bridging the 
Rsp5-Ubp2 interaction. This is consistent with the genetic interaction shown in figure 
2.9A, where Rup1 overexpression inhibited the growth of the rsp5-1 mutant, wherease 
Rup1 deleted of UBA domain did not, suggesting a critical role of the UBA domain in 
the Ubp2 activitiy. The UBA domain also partially stimulated the deubiquitinating 
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      1     2     3      4      5     6     7      8     9 
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 Ub4 - 
 Ub3 - 
 Ub2 - 
 Ub1 - 
Ubp2 :     -      -      -     +     +     +     ++  ++   ++ 























Figure 2.14 UBA domain of Rup1 stimulates Ubp2-catalyzed disassembly of both free 
K63-linked chains and substrate-linked K63-polyubiquitins. (A) Disassembly of free 
K63-linked chains were assayed using low concentration of Ubp2 in the presence of no 
Rup1 (-), Rup1 (WT), and Rup1-∆UBA (∆) proteins. After 30 minutes of the 
deubiquitinating reaction at room temperature, the products were stopped by adding 1X 
SDS-loading buffer and analyzed by 12% SDS-PAGE followed by Coomassie stain. 
Ubp2:     -      -       -      -     1X   1X   1X   5X   5X   5X 
  Rup1:    -       -     WT   ∆     -     WT   ∆      -     WT   ∆ 
A. 
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(B). Same assays were performed using pre-ubiquitinated 35S-labeled WBP2. After 30 
minutes, the products were analyzed by 8% SDS-PAGE followed by autoradiography. 
  The genetic and biochemical evidence described so far are consistent with the 
model that Ubp2 antagonizes Rsp5-mediated substrate ubiquitinaiting activities. An 
important question is whether Ubp2 deubiquitinates only a subset of Rsp5 substrates or 
all of the substrates. Based on the stoichiometry analysis from the TAP-Rsp5 pulldown, it 
appears that the ratio of TAP-Rsp5 to Ubp2 might be greater than 1:1 (see figure 2.1), 
suggesting that not all Rsp5 is in a complex with Ubp2. To better address this issue, gel 
filtration analysis was performed to see if Ubp2 and Rsp5 move together in same 
fractions using TAP-UBP2 cell extracts (Figure 2.15). Since it was previously shown that 
both Rsp5 and Ubp2 bind to DEAE anion exchange column and eluted by high salts (not 
shown, see figure 2.4A), the cell extracts were first partially purified by DEAE sepharose 
to increase the purity. Surprisingly, TAP-Ubp2 was present in only few fractions, 
wherase Rsp5 was distributed into many fractions in the S300 column, suggesting that 
only a subset of Rsp5 proteins are in complex with Ubp2, and this is consistent with the 
stoichiometry analysis from the TAP-Rsp5 pulldown. However, it still remains to be 
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Figure 2.15 Gel filtration analysis of Rsp5/Ubp2 complex. First, cell extracts from 30 
ml of TAP-UBP2 (YK005) strain was partially purified on DEAE-sepharose and eluted 
by 500mM NaCl (see materials and methods). The high-salt eluted fraction was subject 
to S300 size exclusion column. Equal amounts of fractions were collected and analyzed 
by 10% SDS-PAGE, followed by western blotting using either anti-Rsp5 or anti-TAP 
antibodies (for detecting TAP-Ubp2). 
 
 
Figure 2.13 showed that bacterially purified Ubp2 reverses Rsp5-mediated 
polyubiquitination of WBP2 and Spt23 in vitro. To further test whether Rsp5 is 
associated with catalytically active Ubp2 from yeast cell extracts, GST-pulldown assay 
was done using bacterially purified GST-Rsp5 on glutathione sepharose (Figure 2.16). 
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The GST-Rsp5 was pre-incubated with yeast cell extracts before it was used for 
deubiquitination assays. The substrate WBP2 was ubiquitinated in separate reactions, 
prior to the deubiquitination assay. To our expectation, when the pre-incubated GST-
Rsp5 was added to the ubiquitinated WBP2, efficient deubiquitination was observed, 
suggesting that GST-Rsp5 purified active Ubp2 from the yeast cells. Notably, when 
GST-Rsp5 was pre-incubated with ubp2∆ cell extracts, no deubiquitination of WBP2 
was detectable, suggesting that the deubiquitination activity purified from wild type cell 
extracts were due to Ubp2. Furthermore, this suggests that Ubp2 is the only 
deubiquitinating enzyme associated with Rsp5 in cells. As will be discussed in chapter 
5, this type of assay can be used as a test whether the mammalian homologues of Rsp5 
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Pulldown:                      GST    GST-Rsp5














Figure 2.16 GST or GST-Rsp5, on sepharose beads, was used to isolate Ubp2 
deubiquitinating activity from cell extract of either WT (UBP2) or ∆ (ubp2∆). After 
washing, the beads were incubated with pre-ubiquitinated 35S-labeled WBP2 (lane1, 
unmodified input; lane 2, pre-ubiquitinated input). Deubiquitination of WBP2 was only 
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2.4 Discussion 
The results presented here represent a unique demonstration of the physical 
coupling of an HECT ubiquitin ligase with a DUB for the purpose of modulating 
substrate modification. At least four examples of specific interactions between ubiquitin 
ligases and DUBs have been previously reported. These involve the human Nrdp1 ligase 
and USP8 (239), the herpes simplex virus ICP0 ligase and USP7 (18), the 
TRAF2/TRAF6 ligases and CYLD (17, 127, 220), and the VHL ligase and the VDU1 
and VDU2 DUBs (138). The ligases in the first three cases are RING domain E3s that 
undergo autoubiquitination, and in all cases, the DUB has been proposed to reverse the 
autoubiquitination. In contrast, our results strongly suggest that Ubp2 modulates 
ubiquitination of Rsp5 substrates, including Spt23, rather than self-ubiquitination of Rsp5. 
Rsp5 has not been shown to undergo autoubiquitination in vivo, consistent with the 
observations that the half-life of wild-type Rsp5 is similar to that of the active-site 
cysteine mutant of Rsp5 (227), and overexpression or deletion of Ubp2 does not affect 
the steady-state level of Rsp5 (not shown). More similar to the Rsp5–Ubp2 relationship, 
the VHL-associated DUB, VDU2, appears to rescue a VHL substrate (HIF-1a) from 
degradation (138). In this case, however, VDU2 interacts directly with the substrate, 
whereas our results suggest that substrate specificity of Ubp2 is likely to be conferred 
through its Rup1- dependent association with Rsp5.  
Rsp5 and Ubp2 only formed a stable complex in the presence of Rup1, and 
genetic relationships were consistent with the notion that Rup1 cooperates with Ubp2 to 
antagonize Rsp5 activity. While the UBA domain of Rup1 was not required to mediate 
  95 
formation of the ternary complex in vitro, the UBA domain was necessary for stimulation 
of Ubp2 activity against free K63 chains at limiting concentrations of Ubp2. It will be of 
interest to determine whether the Rup1 UBA domain binds polyubiquitin chains, as 
reported for other UBA domains (24, 179, 233), and whether it interacts preferentially 
with K63-linked chains. We speculate that the UBA domain might aid in presenting 
polyubiquitin chains to Ubp2 or, alternatively, might aid in stabilizing an active 
conformation of Ubp2. The chain specificity of Ubp2 was the same in the absence or 
presence of Rup1, indicating that this is an inherent characteristic of the enzyme, rather 
than an Rsp5- or Rup1-dependent effect. A few DUBs have been reported to disassemble 
both K48- and K63-linked chains in vitro, including Cezanne/A20 (59, 232), 
Ubp14/isopeptidase T (61), and CYLD (127, 220), while AMSH, a JAMM motif 
isopeptidase, has been shown to have a strong preference for disassembly of K63 chains 
(157).  
While Ubp2 and Rsp5 catalyze opposing reactions, it was conceivable that 
coupling of Ubp2 to Rsp5 activities might promote, rather than antagonize, at least a 
subset of Rsp5 functions. For example, Spt23 has been reported to be monoubiquitinated 
in vivo (180). Ubp2 could conceivably promote Rsp5 function by limiting chain 
extension to favor monoubiquitination. In contrast, there are examples of DUBs that 
rescue substrates from ubiquitination (25, 110, 139). The observed genetic interactions 
between RSP5 and UBP2 are most consistent with the latter examples, and suggest a 
model in which Ubp2 rescues Rsp5 substrates from ubiquitination. An antagonistic 
relationship between Rsp5 and Ubp2 was supported by the observations that (1) 
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overexpression of UBP2 in the rsp5-1 background resulted in a strong growth 
suppression, (2) rsp5-1 temperature sensitivity was rescued by either the ubp2∆ or rup1∆ 
mutations, and (3) the ubp2∆ mutation sensitized cells to the effects of Spt23 
overexpression. It is not known whether all functions of Rsp5, or only a subset, are 
subject to modulation by Ubp2.  
There are nine human homologs of Rsp5 (e.g., WWP1/2, Smurf1/2, Nedd4, Itch) 
involved in various functions, including disease states (Liddle’s syndrome, Epstein–Barr 
virus latency), the life cycle of several budding viruses, and TGFß signaling (reviewed in 
(110). The results presented here raise the question of whether the activities of these 
enzymes are also modulated by physically coupled DUBs. The fact that many of the 
functions of the mammalian Rsp5 homologs are also related to trafficking of membrane 
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3.1 Introduction 
              Ubiquitination of target proteins is catalyzed by a cascade of at least 3 classes of 
enzymes, known as E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes, 
and E3 ubiquitin ligases (discussed in detail in chapter 1) (174). There are two main 
classes of E3 ubiquitin ligases, known as HECT and RING E3s. HECT E3s participate 
directly in the chemistry of ubiquitin conjugation by forming a covalent thioester 
intermediate with ubiquitin at an active site cysteine residue within the HECT domain 
(193), while RING E3s appear to function as docking surfaces for activated E2s and 
substrates. Rsp5 is the best characterized HECT E3 in Saccharomyces cerevisiae and 
direct homologs of Rsp5 (the Nedd4 family of HECT E3s) exist in all animals (110). 
RSP5 is the only essential gene among the five HECT E3s in budding yeast (227), and 
the minimal essential function of Rsp5 is the ubiquitination of the Spt23 transcription 
factor, leading to a proteasome-catalyzed processing event that is required for its 
activation (99). Rsp5 has been reported to function in a variety of other cellular processes 
including ubiquitin-mediated endocytosis of plasma membrane proteins such as Gap1 
(66), Fur4 (206), and Ste2 (50), and the delivery of biosynthetic cargo, such as Cps1, into 
the endosomal lumen (117). Rsp5 has also been implicated in RNA export (166), 
ubiquitination of the large subunit of RNA pol II (107), mitochondrial inheritance (64), 
and cell wall biogenesis (114), indicating that Rsp5 is a multifunctional protein capable 
of ubiquitinating many substrates in many different locations. 
               Ubiquitination is a reversible process in that the isopeptide bond between 
ubiquitin and a substrate protein, as well as isopeptide bonds between ubiquitin 
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molecules in a polyubiquitin chain, can be cleaved by deubiquitinating enzymes (DUBs). 
There are at least 18 DUBs characterized in S. cerevisiae to date, including 16 ubiquitin 
specific proteases (UBPs), an ubiquitin C-terminal hydrolase (UCH), and a JAMM motif 
metalloprotease. The best characterized function of DUBs is to facilitate the rescue of 
ubiquitin monomers from proteolytic degradation. For example, Doa4/Ubp4 is an 
endosomal membrane associated protease that cleaves ubiquitin molecules from 
endocytic cargo prior to vacuolar degradation, thus maintaining total cellular ubiquitin 
pools (5, 52), and Ubp6 is a proteosome-associated enzyme that is required for ubiquitin 
homeostasis and thought to rescue ubiquitin molecules prior to proteosomal degradation 
of substrates (133). Other roles of the DUBs include processing of ubiquitin precursors to 
mature forms and reversing ubiquitination of substrates (4). There have been several 
reports of E3s that are physically associated with DUBs (18, 89, 239), and in these cases 
the DUBs reverse autoubiquitination of the E3s, thus increasing the stability of the E3 by 
protecting them from proteosomal degradation. Recently, Rsp5 has been shown to be 
physically associated with Ubp2 (120). Autoubiquitination of Rsp5 in vivo has not been 
previously reported and the half-life of Rsp5 is unaffected by its catalytic activity, 
suggesting that Ubp2 does not regulate the stability of Rsp5.  Rather, genetic and 
biochemical evidence indicated that Ubp2 antagonizes Rsp5-mediated ubiquitination of 
target proteins (120). The interaction of Rsp5 and Ubp2 is indirect and is mediated by a 
third protein, Rup1.  Rup1 contains a UBA ubiquitin binding domain and no other 
characterized functional domains or motifs.   
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  Ubiquitin contains seven lysine residues that can potentially serve as acceptor 
sites for additional ubiquitin molecules to form polyubiquitin chains. K48-linked 
polyubiquitin chains are the primary signal for targeting to the 26S proteasome, while 
monoubiquitination and other forms of polyubiquitin chains appear to mediate alternative 
functions (21, 63, 91). K63-linked chains serve non-proteolytic functions in DNA repair 
pathways (94, 208), kinase activation (43), and receptor endocytosis (66, 206), although 
they may also be capable of proteasome targeting (187). K29-linked chains were reported 
to be a degradation signal and recently shown to lead to an endocytic signal (20, 111), 
and K6-linked chains have been implicated in a DNA repair pathway (237). The 
functions of polyubiquitin chain types are summarized in Illustration 3.1.  
In this chapter, I show that Rsp5 preferentially catalyzes K63-linked 
polyubiquitination of substrates in vitro, while Ubp2 preferentially disassembles K63 
chains in vitro. Furthermore, Rsp5 and Ubp2 modulate a significant fraction of K63-
linked polyubiquitination in vivo, and the essential function of Rsp5 at elevated 
temperature requires K63 polyubiquitination. These findings will provide excellent tools 
for identification and characterization of biochemical mechanisms for the synthesis of 
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Illustration 3.1 Functions of different polyubiquitin chain types. Left. Relevent features 
of ubiquitin. The seven lysine residues are shown in red, while the L8–I44–V70 
hydrophobic patch is shown in gold ball-and-stick. Reprinted from Pickart and 
Fushman (175). Copyright (2004), with permission from Elsevier. Right. Characterized 
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3.2 Materials and methods 
Yeast strains, media, and plasmids 
A list of yeast strains is shown in Table 1. SUB492 and SUB493 strains were 
generous gifts from Dr. Dan Finley and express wild type and K63R ubiquitin as a sole 
source of ubiquitin, respectively, as previously described (208) (see table 3.1). ubp2∆ 
mutations were introduced into both SUB492 and SUB493 strains using kanamycin 
(KanMX6) selection, as previously described (120) (see chapter 2), generating YK018 
and YK019, respectively. pUB39 is a Lys2-marked plasmid that expresses wild type 
ubiquitin under the CUP1 promoter. pUB115, pUB192, pUB195, and pUB197 are 
identical to pUB39, except for the K48R, K6R, K29R, and K63R mutations in the 
ubiquitin, respectively (208), and were generous gifts from Dr. Dan Finley. Plasmids for 
overexpressing UBP2 and ubp2C745S were described previously in chapter 2. For the 
ADCB containing media, ADCB (Sigma) was dissolved in water and added to synthetic 
minimal media as final concentrations of 100 or 200ug/ml where indicated. For the CFW 
containing media, CFW (Sigma) was dissolved in water and added to YPD media as final 
concentrations of 5 or 7ug/ml where indicated. 
 
Protein interaction assays 
 GST-fusions of Rsp5 and Ubp2C-S were expressed from the pGEX6p-1 
(Amersham Biosciences) in Escherichia.coli DH5α strain by standard methods and 
affinity-purified on glutathione-Sepharose (Amersham Biosciences). The purified 
proteins were cleaved from GST using PreScission protease (Amersham Biosciences) 
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under the manufacturer's recommended conditions. For the pulldown of ubiquitin 
conjugates from the wild type (BY4741) and ubp2∆ (YK009) cell extracts, cells in mid-
log phase  (typically 30 O.D) were lysed with a bead beater in NP40 lysis buffer (1% 
NP40, 150mM NaCl, 50mM Tris pH 7.0) in the presence of protease inhibitors (leupeptin, 
aprotinin, PMSF). Cell extracts were cleared by centrifugation at 14,000 rpm for 10 
minutes before they were subject to GST-Rsp5 or GST-Ubp2C-S sepharose. The binding 
reactions were left for 2 hours at 4°C and the beads were washed with the NP40 buffer 
for 3 times before analyzing by 8% SDS-PAGE. The gels were electro-blotted onto 
nitrocellulose membranes and western blot analyses were performed using monoclonal 
anti-ubiquitin antibody (Santacruz Biotech.) 
 
In vitro ubiquitination/deubiquitination assays 
In vitro ubiquitination and deubiquitination assays were performed in the presence of 
10mM Tris pH 7.5, 50mM NaCl, 5mM ATP, 5mM MgCl2, 0.1mM DTT, and 50ug/ml 
ubiquitin (Sigma). Bacterially expressed Rsp5, Rup1, and Ubp2 were purified on 
glutathione sepharose and GST was removed by cleavage with PreScission protease 
(Amersham Biosciences). Human E1, UbcH7, E6AP, and HPV16 E6 proteins were 
expressed in High5 insect cells (Invitrogen) using recombinant baculoviruses. Cell lysates 
were made 48-hours post-infection in NP-40 lysis buffer (1% NP40, 100 mM Tris, pH 7.5, 
100 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 mM DTT), affinity-
purified on glutathione-Sepharose, and cleaved from GST with PreScission protease. In 
vitro translated 35S-labeled p53, Scribble, WBP2, synthesized using transcription and 
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translation coupled (TNT) rabbit reticulocyte lysate (Promega), were used as substrates. 
The ubiquitination reactions were performed as previously described in chapter 2. 
Ubiquitination reactions were carried out for 30 min at room temperature, followed by an 
additional 30 min for deubiquitination by Rup1/Ubp2. For the assays using K0, K48-only, 
K63-only ubiquitin (Boston Biochem), the in vitro translated substrates were partially 
purified by DEAE anion exchange column to remove endogenous ubiquitins. Briefly, the 
in vitro translation mixtures were prepared in 50-100ul of volumes. The lysates were 
diluted 3-4 fold with the ion exchange binding buffer (50mM Tris pH7.0, 20mM NaCl), 
supplemented with DTT of final 10mM concentration to cleave thioester-bound 
ubiquitins from E1 and E2s. 30ul of DEAE sepharose (Amersham Biosciences) 
equilibrated with the same buffer was added to the diluted lysates and incubated for 20 
minutes at 4C. The beads were harvested at 2,500 rpm and the supernatant was removed, 
followed by 3 times of extensive washing with the same buffer. The bound proteins were 
eluted by adding 50-100ul of 500mM NaCl for 10 minutes. The ubiquitination reactions 
were performed as described in chapter 2 and the reactions were stopped by addition of 
SDS-PAGE loading buffer and the samples were analyzed on 8% SDS-PAGE gel, 
followed by autoradiography. The deubiquitination assays using free ubiquitin chains 
utilized 3ugs of either K48 or K63 polyubiquitin chains 3-7 (Boston Biochem), and were 
incubated with 0.15–15 ng of purified Ubp2 for 1 h at room temperature in buffer 
containing 10mM Tris pH 7.5, 50mM NaCl, 5mM MgCl2, and 0.1mM DTT. The 
reactions were stopped by adding 1X SDS–PAGE loading buffer and products were 
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Strain Genotype References 
FY56 MATα his4-912δR5 lys2-128δ ura3-52 (107) 
YK001 MATα NTAP-RSP5 his4-912δR5 lys2-128δ ura3-52 (120) 
FW1808 MATα rsp5-1 his4912δR5 lys2-128δ ura3-52 (107) 
YK003 MATα rsp5-1 ubp2::KANMX6 his4912δR5 lys2-128δ ura3-52 (120) 
YK004 MATα rsp5-1 rup1::KANMX6 his4912δR5 lys2-128δ ura3-52 (120) 
BY4741 MATa his3 leu2 met15 ura3 Open Biosystems 
YK009 MATa ubp2∆::KanMX6 his3 leu2 met15 ura3 Open Biosystems 
SUB492 MATa lys2-801 leu2-3,112 ura3-52 his3-∆ 200 trp1-1[am] ubi1-∆ 1::TRP1 
ubi2-∆ 2::ura3 ubi3-∆ ub-2 ubi4-∆ 2::LEU2 [pUB39][pUB100] 
(208) 
SUB493 Isogenic to SUB492 except for pUB197 instead of pUB39 (208) 
YK018 
MATa ubp2∆::KanMX6 lys2-801 leu2-3,112 ura3-52 his3-∆ 200 trp1-1[am] 
ubi1-∆ 1::TRP1 ubi2-∆ 2::ura3 ubi3-∆ ub-2 ubi4-∆ 2::LEU2 
[pUB39][pUB100] 
(121) 
YK019 Isogenic to YK018 except for pUB197 instead of pUB39 (121) 
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3.3 Results 
Rsp5 and Ubp2 assembles and disassembles K63-linked polyubiquitin chains in vitro 
 In chapter 2, it was shown that Ubp2 disassembles at least two substrates of Rsp5, 
prompting a next question whether Ubp2 can disassemble any kind of polyubiquitinated 
proteins. To further investigate the biochemical activity of Ubp2 in vitro, it was tested if 
Ubp2 can deubiquitinate the E6/E6AP-catalyzed polyubiquitin chains on two substrates, 
p53 and Scribble (Figure 3.1). Surprisingly, Ubp2 did not deubiquitinate the E6AP-
catalyzed polyubiuitin chains under the same condition where it efficiently 
deubiquitinated Rsp5 substrates (Figure 2.13 in chapter 2). Two possible mechanisms 
may explain the discriminatory activity of Ubp2. First, the molecular interaction between 
Rsp5 and Ubp2 might be critical for the deubiquitinating activity. Second, the type of 
chains synthesized by Rsp5 and E6AP-catalyzed reactions might be different, leading to 
differential disassembly by Ubp2. In fact, it was known previously that E6AP catalyzes 
almost exclusively K48-linked chains in vitro (140), while it was shown that at least 
some of the natural substrates of Rsp5 are modified by K63-linked polyubiquitin chains 
in vivo (52, 64, 66, 206). I therefore investigated the relative preference of Rsp5 and 
Ubp2 for K63 chain assembly and disassembly, respectively. I performed ubiquitination 
assays in the presence of ubiquitin in which all lysine residues were altered to arginine 




  108 
E6/E6AP:       +     - +    +    +              +      - +     +
Ubp2p:       - - - +    +              - - +     +
Rup1p:       - - +     - +              - - - +
p53
Scribble
















Figure 3.1 Ubp2 does not reverse E6/E6AP-catalyzed ubiquitination reaction in vitro. 
E6AP-mediated ubiquitination of 35S-labeled p53 (left) and Scribble (right) was 
performed in the presence of E6, E1, E2 (UbcH7), Ub, ATP. After 30 minutes of the 
ubiquitination reaction, Rup1 and/or Ubp2 were added and incubated for additional 30 
minutes, as described previously. The reactions were stopped by adding 1X SDS-
loading buffer and the total products were analyzed by 8% SDS-PAGE and visualized 
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The endogenous ubiquitin present in the in vitro translation reactions was first 
depleted by anion exchange chromatography (DEAE), and as expected, there was no 
detectable ubiquitination in the absence of added ubiquitin (Figure 3.2). The addition of 
wildtype ubiquitin, K48-only ubiquitin, or K63-only ubiquitin resulted in a similar degree 
of overall substrate modification (i.e., the amount of remaining unmodified substrate was 
similar; lanes 3–5). However, the average length of the polyubiquitin chains was shorter 
in the presence of K48-only ubiquitin relative to wild-type ubiquitin, while the average 
chain length was longer in the presence of K63-only ubiquitin. This is the first 
demonstration that Rsp5 preferentially synthesizes K63-linked polyubiquitins in vitro, 
consistent with its reported role in the endocytosis of membrane proteins (66, 206). When 
Ubp2 was added in the reactions, the extent of deubiquitination was similar in the 
reactions containing wild-type and K63-only ubiquitin, while there was significantly less 
deubiquitination seen in the K48-only reaction. Experiments with ubiquitin in which all 
lysines were mutated to arginines suggested that much of the multiubiquitination 
observed with K48-only ubiquitin was actually the result of monoubiquitination at 
multiple lysines of the substrate (not shown). Together, these results suggest that Rsp5 
preferentially assembles K63-linked chains, while Ubp2 preferentially disassembles K63 
chains. Similar experiments with E6/E6AP-catalyzed reactions confirmed that E6AP 
catalyzed almost exclusively K48-linked chains to both p53 and Scribble, and again, 
Ubp2 did not disassemble these conjugates (not shown).  
 
 







































































Figure 3.2 Rsp5 and Ubp2 preferentially assemble and disassemble K63-linked 
polyubiquitin chains. (A) Rsp5-catalyzed ubiquitination reactions were carried out with 
35S-labeled WBP2 as a substrate, as in Figure 13 of chapter 2, except that the 
endogenous ubiquitin present in the translation reaction was first removed by DEAE 
anion exchange chromatography. The reactions were then performed in the absence of 
added ubiquitin (left panel, lane 2) or the presence of wild-type ubiquitin, K48-only 
ubiquitin, or K63-only ubiquitin (left panel, lanes 3–5). Deubiquitination (lanes 6–8) 
was initiated after 30 min by the addition of Ubp2 and Rup1. Control reactions (lanes 
9–11) show that the ubiquitination reaction was dependent on added E2 (Ubc1) and 
Rsp5. (B) E6/E6AP-catalyzed ubiquitination reactions were performed as in (A). The 
products were stopped by adding 1X SDS-loading buffer, analyzed by 8% SDS-PAGE, 
followed by autoradiography. 
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To confirm the apparent preference of Ubp2 for K63-linked chains, 
deubiquitination assays were carried out using free purified K63 or K48 chains as 
substrates over a 100-fold range of Ubp2 concentration. As shown in Figure 3.3, at 
equivalent enzyme concentrations, Ubp2 showed a strong preference for hydrolysis of 
K63-linked chains, although there was reactivity against K48-linked chains at higher 
concentrations of Ubp2. This suggests that the inherent preference of Ubp2 for K63-





















Figure 3.3 Ubp2 preferentially disassembles K63-linked free polyubiquitin chains. 
Purified K48 and K63-linked polyubiquitin chains (Ub3-Ub7; Boston Biochem) were 
assayed as substrates of purified Ubp2 protein over 100 fold range of Ubp2 
concentration. The deubiquitination reactions were performed for 30 minutes at room 
temperature and the reactions were stopped by 1X SDS-loading buffer. The samples 
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Modulation of K63 polyubiquitin conjugates by Rsp5 and Ubp2 in vivo. 
To further analyze the Ubp2 activity in vivo, I compared the amount of overall 
ubiquitin conjugates in total cell extracts from wild type UBP2 and ubp2∆ cells. 
Unexpectedly, a strong increase in total ubiquitin conjugates was seen in ubp2∆ cells 
compared to the  wild type cell extracts, as determined by immunoblotting with anti-
ubiquitin antibody (Figure 3.4A), suggesting that the increased ubiqutitin-conjugates are 
likely to be the physiologic substrates of Ubp2. To confirm this, a plasmid-based UBP2 
gene under GAL1 promoter control was reintroduced into the ubp2∆ cells (Figure 3.4B).   
Consistent with the result in figure 3.4A, the exogenous UBP2 overexpression reduced 
the conjugate level below that seen in the wild-type UBP2 strain, while reintroduction of 
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Figure 3.4 Ubp2 modulates K63-linked conjugates in S. cerevisiae. (A) Total ubiquitin 
conjugates were compared in total extracts of UBP2 (BY4741) and ubp2∆ (YK009) 
cells by immunoblotting with anti-ubiquitin antibody. An anti-Rpa1 immunoblot (anti-
70K) is shown of the same extracts as a loading control.  (B) Total ubiquitin conjugates 
in the ubp2∆ mutant were examined as in A. upon overexpression of wild type Ubp2 or 
the catalytically inactive Ubp2-C745S (C-S) proteins. (C) Total ubiquitin conjugates in 
cell extracts from wild type ubiquitin (SUB492), wild type ubiquitin/ubp2∆ (YK018), 
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K63R ubiquitin (SUB493), and K63R ubiquitin/ubp2∆ (YK019) strains were compared 




Based on the in vitro activities of Ubp2 in figure 3.2 and 3.3, it is likely that the 
increased ubiquitin conjugates in the ubp2∆ mutants represent accumulation of K63-
linked polyubiquitin chains. To test this, I took advantage of the strains in which all four 
endogenous ubiquitin genes were eliminated and replaced by a plasmid-borne wild-type 
ubiquitin gene, or a mutated ubiquitin gene encoding K63R ubiquitin (208). The 
expressions of exogenous ubiquitin genes are under control of the copper-inducible 
CUP1 promoter, and it was shown that the basal non-induced level of the promoter 
activity result in approximately similar levels of ubiquitins in the cells compared to the 
sum of all four endogenous ubiquitins. The ubp2∆ mutations were introduced into both of 
these strains and it was confirmed that the growth of the resultant strains were all normal 
compared to the wild type UBP2 strains (not shown). Consistent with figure 4A, the 
ubp2∆ mutation led to an increase in ubiquitin conjugates in the strain expressing wild 
type ubiquitin (Figure 3.4C). Interestingly, although expected, the ubp2∆ mutation in the 
K63R strain resulted in only a slight accumulation of conjugates, strongly suggesting that 
the vast majority of the elevated ubiquitin conjugates in the ubp2∆ mutant represented 
K63-linked chains. However, the small but consistently increased level of ubiquitin 
conjugates were observed in the ubp2∆ /K63R strain, suggesting that Ubp2 may have a 
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limited capacity to recognize polyubiquitin linkages other than K63, or possibly 
monoubiquitins (lane 4 of figure 3.4C). 
The ubp2∆ mutation conferred increased sensitivity to the toxic proline analogue 
L-azetidine-2-carboxylic acid (ADCB; Figure 3.5A) (182), suggesting that hyper-K63 
polyubiquitination of one or more proteins leads to ADCB hypersensitivity. Consistent 
with this, the ubp2∆ mutant did not display increased ADCB sensitivity in cells that 
expressed K63R-ubiquitin as the sole source of ubiquitin (Figure 5A, upper left panel). 
Even in a wild-type UBP2 background, cells expressing K63R ubiquitin as the sole 
source of the ubiquitin were resistant to ADCB compared to the wild type ubiquitin strain, 
further indicating that K63-linked polyubiquitination is required to confer sensitivity to 
ADCB (Figure 3.5A, lower left upper). GAL1 promoter-driven expression of UBP2 in the 
ubp2∆ mutant conferred ADCB resistance beyond that of wild-type UBP2 cells, while 
overexpression of the C-S mutant did not suppress ADCB sensitivity (Figure 3.5B).  
Ren et al (182) showed that in ubp2∆ or rup1∆ cells, GFP-Gap1 general amino 
acid permease is stabilized at the plasmamembrane even in a nitrogen-replete condition, 
suggesting that Ubp2 and Rup1 are required for the receptor endocytosis, presumably 




































Figure 3.5 ADCB sensitivity of the ubp2∆ mutant. (A) Top: UBP2 (BY4741), ubp2∆ 
(YK009), wild type ubiquitin/ubp2∆  (YK018), and K63R ubiquitin/ubp2∆ (YK019) 
cells were 10-fold serially diluted and  spotted on either synthetic minimal (SD) media 
or SD containing 100ug/ml of ADCB and grown at 30°C for 3 days. Bottom: Wild type 
ubiquitin (SUB492) and K63R ubiquitin (SUB493) cells were 10-fold serially diluted 
and spotted on either synthetic minimal (SD) media or SD containing 100ug/ml of 
ADCB and grown at 30°C for 3 days.  (B) UBP2 overexpression increases resistance of 
cells to ADCB. The indicated strains were 10-fold serially diluted and spotted on either 
synthetic media containing galactose with or without 200ug/ml of ADCB and grown at 
30°C for 4 days. 
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Together, the results shown in Figure 3.4 and 3.5 indicate that the ubp2∆  mutation 
leads to an overall accumulation of K63-linked polyubiquitin conjugates in vivo. To 
determine whether the conjugates that accumulate are the result of Rsp5 ubiquitination 
activity, I analyzed the effect of the rsp5-1 hypomorphic temperature-sensitive mutation 
on the accumulation of conjugates. A strong reduction in overall conjugates was observed 
in the rsp5-1/ubp2∆ mutant compared to RSP5/ubp2∆ cells (Figure 3.6A), both at normal 
and elevated growth temperatures. This result strongly suggests that the majority of 
ubiquitin conjugates that accumulate in the ubp2∆ strain are the result of Rsp5-dependent 
ubiquitin conjugation, consistent with the previous demonstration that Rsp5 preferentially 
catalyzes conjugation of K63-linked chains in vitro (Figure 3.2).  
To further demonstrate that Rsp5 catalyzes K63 chain formation in vivo, wild-
type ubiquitin and K63R ubiquitin were overexpressed in the rsp5-1 mutant (Figure 3.6B, 
top). It was previously reported that overexpression of ubiquitin can rescue the 
temperature sensitivity of rsp5-1 strain (129). The premise was that if K63-linked 
polyubiquitin chain formation is critical for the Rsp5 activity, overexpression of K63R 
ubiquitin should not rescue the hypomorphic rsp5-1 strain. Consistent with the previous 
report, overexpression of wild type ubiquitin under the CUP1 promoter rescued growth 
defect of the rsp5-1 mutant at elevated temperature (35C), although I could not 
recapitulate the rescue at 37C, at as it was reported (not shown). Interestingly, 
overexpression of K63R ubiquitin did not rescue the growth defect, suggesting that K63-
linked polyubiquitin chain formation is critical for the Rsp5 activity at the elevated 
temperature. This is consistent with previous observation that growth of the K63R is 
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severely inhibited at 37C (208). Overexpression of the ubiquitins did not affect the 
growth of wild type RSP5 strain at both 30C and 37C (Figure 3.6B lower panels). To 
further investigate the chain type requirement for rescue, K6R, K29R, or K48R ubiquitin 
were overexpressed in the mutant (Figure 3.6C). As expected, overexpression of K6R 
and K48R ubiquitins rescued rsp5-1 temperature sensitivity, suggesting that neither 
formation of K48 or K6-linked chains are essential activity of Rsp5 at highy temperature. 
Interestingly, rescue by K29R ubiquitin was only partial compared to the wild type 
ubiquitin. These results demonstrate that the ability of Rsp5 to form K63-linked 
conjugates is linked to its essential function at elevated temperature, although they do not 
rule out that Rsp5 might synthesize other types of polyubiquitin chains in vivo, 
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Figure 3.6 Rsp5 catalyzes K63-linked polyubiquitination in vivo. A. Total ubiquitin 
conjugates were compared in cell extracts from ubp2∆ (YK009) and rsp5-1/ubp2∆ 
(YK003) strains by anti-ubiquitin immunoblotting.  B. rsp5-1 (FW1808) cells 
transformed with empty plasmid, plasmids expressing wild type ubiquitin (pUb-WT; 
pUB39), K63R ubiquitin (pUB-K63R; pUB197), K48R ubiquitin (pUB-K48R; pUB115), 
K6R ubiquitin (pUB-K6R; pUB192), or K29R ubiquitin (pUB-K29R; pUB195) under 
CUP1 promoter control were 10-fold serially diluted and plated on minimal media and 





Rsp5 and Ubp2 regulate cell wall homeostasis.  
The temperature sensitivity of rsp5 mutants can be partially rescued by sorbitol, 
an osmotic stabilizer (120, 244), and a recent report also indicated that Rsp5 affects cell 
wall integrity (114).  An assay that reflects the effect of rsp5 mutations on cell wall 
integrity is sensitivity to calcofluor white (CFW), a chitin binding molecule. Changes in 
the sensitivity to this drug are generally thought to be indicative of changes in the cell 
wall structure and/or chitin level (114). As shown in Figure 3.7A, the rsp5-1 mutant 
was sensitive to CFW at 30°C, consistent with the previous report in Kaminska et al. 
According to the model that Rup1 and Ubp2 functionally antagonize Rsp5, we 
predicted that ubp2 or rup1 mutations would lead to increased Rsp5 activity and 
therefore rescue CFW sensitivity of the rsp5-1 mutant. Indeed this was the case (Figure 
3.7A), indicating that Rup1/Ubp2 activity and Rsp5 activities are balanced, in part, to 
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achieve cell wall homeostasis. However, it is not clear whether this reflects differences 
in chitin level of the cell wall among the mutants, as CFW staining of the yeast cells did 
not reveal obvious difference (not shown). As with ADCB sensitivity, CFW sensitivity 
of the rsp5-1 strain was also linked to formation of the K63-polyubiquitin conjugates. 
Overexpression of wild-type ubiquitin suppressed the CFW sensitivity of the rsp5-1 
mutants, while overexpression of K63R ubiquitin did not, and in fact, led to the 
increased CFW sensitivity (Figure 3.7B). Consistent with this notion, the K63R-only 
ubiquitin strain (K63R ubiquitin as the sole source of ubiquitin), itself, was also 
hypersensitive to CFW compared to the equivalent wild-type ubiquitin strain (Figure 
3.7C), further indicating that formation of K63-polyubiquitin conjugates by Rsp5 is 
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Figure 3.7 Ubp2 and Rup1 modulate effects of Rsp5 on cell wall homeostasis. A.  
Deletion of ubp2 or rup1 rescues CFW sensitivity of the rsp5-1 strain. RSP5 (FY56), 
rsp5-1 (FW1808), rsp5-1/ubp2∆ (YK003), and rsp5-1/rup1∆ (YK004) cells were 6-
fold serially diluted and plated on either YPD or YPD plates containing 5ug/ml of CFW. 
Cells were grown at 33°C for 4 days. B. Overexpression of wild type ubiquitin, but not 
K63R ubiquitin, rescues CFW sensitivity of rsp5-1 strain. rsp5-1 (FW1808) strain 
transformed with a empty plasmid, plasmid expressing wild type ubiquitin (pUb-WT; 
pUB39) or K63R ubiquitin (pUb-K63R; pUB197) were 10-fold serially diluted and 
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plated on YPD plates with or without 5ug/ml of CFW and grown at 30°C for 2 days. C. 
K63-linked polyubiquitination is required for resistance to CFW. Wild type ubiquitin 
(SUB492) and K63R-only ubiquitin cells (SUB493) were 10-fold serially diluted and 
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3.4 Discussion 
Rsp5 is the first HECT E3 to be shown to display a distinct preference for 
assembly of K63-linked polyubiquitin chains in vitro. Human E6AP preferentially 
catalyzes K48 linkages, consistent with its role in targeting p53 for proteasomal 
degradation (195), while the synthesis of K63 chains by Rsp5 is consistent with reports 
that have shown that some Rsp5-mediated functions are dependent on K63 of ubiquitin 
(64, 66, 206). Rsp5 has also been linked to proteasomal degradation pathways (10, 57), 
which are predicted to involve K48 or K29 linkages (175). The type of chain synthesized 
by Rsp5 might be regulated by additional factors or perhaps substrate dependent. It 
should be noted that the preferential assembly of K63 chains by Rsp5 was seen when the 
activating E2 enzyme was either yeast Ubc1, human UbcH7, or Arabidopsis Ubc8 (not 
shown), suggesting that K63 chain assembly is an inherent characteristic of Rsp5 and not 
a function of the activating E2 enzyme. While Rsp5 is the only HECT E3 shown to 
preferentially catalyze K63 polyubiquitin linkages, the determinants that confer this 
specificity, relative to K48-specific HECT E3s (e.g., human E6AP), remain to be 
identified.  The strong similarity of Rsp5 to the Nedd4 family of mammalian HECT E3 
suggests that these enzymes might also preferentially catalyze K63-linked 
polyubiquitination.   
The chain specificity of Ubp2 was the same in the absence or presence of Rup1, 
indicating that this is an inherent characteristic of the enzyme, rather than an Rsp5- or 
Rup1-dependent effect. A few DUBs have been reported to disassemble both K48- and 
K63-linked chains in vitro, including Cezanne/A20 (59, 61, 232) Ubp14/isopeptidase T 
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(61), and CYLD (127, 220), while AMSH, a JAMM motif isopeptidase, has been shown 
to have a strong preference for disassembly of K63 chains (157). Consistent with the in 
vitro activity, the data indicated that Ubp2 modulates Rsp5-dependent K63-linked 
polyubiquitination in vivo. To my knowledge, the only S. cerevisiae enzymes other than 
Rsp5 that are known to be dedicated to the generation of K63-linked polyubiquitin chains 
in S. cerevsiae are the Mms2/Ubc13 E2 enzyme complex, which functions in the Rad6-
dependent DNA damage tolerance pathway (97). While other DUBs in yeast are likely to 
have activity against K63-linked chains, Ubp2 is the only yeast deubiquitinating enzyme 
that is known to have a strong preference for disassembly of K63-linked conjugates over 
K48-linked conjugates, both in vitro and in vivo. While the substrate selectivity of 
Mms2/Ubc13 appears to be very restricted in yeast, the dramatic effect of the ubp2∆ 
mutation on accumulation of total K63-linked conjugates, along with the fact that Rsp5 
has a broad range of target proteins, suggests that Rsp5 and Ubp2 may modulate a 
significant fraction of total K63 conjugation activity in yeast.  
A previous report showed that an rsp5 mutant exhibited increased cell wall chitin 
levels and increased sensitivity to CFW (114), and the rsp5-1 mutant was shown here to 
be hypersensitive to CFW. A reflection of a potential cell wall defect of the rsp5-1 was 
our previous observation that the temperature sensitivity of the rsp5-1 strain could be 
rescued by sorbitol, an osomotic stabilizer (120). The fact that both ubp2 and rup1 
mutations rescued the CFW sensitivity of the rsp5-1 mutant is consistent with the 
previous report that the Rup1/Ubp2 deubiquitinating complex antagonizes the function of 
Rsp5 (see Chapter 2). It was shown that an rsp5 mutant displays a significant increase in 
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the chitin level of cell wall compared to wild type cells, suggesting that the basis for the 
sensitivity of the rsp5 mutant to CFW is due to the elevated chitin level, which facilitates 
binding of the drug. Furthermore, electron micrography analysis revealed that the rsp5 
mutant displayed abnormally thick cell wall structure. It will be important to see whether 
deletion of Rup1 or Ubp2 rescues the aberrant cell wall phenotypes of rsp5-1. My 
preliminary studies on CFW staining of cell walls did not reveal difference among the 
mutants, however, the fact that the staining of wile type RSP5 and rsp5-1 cells also 
looked similar (not shown) suggests that CFW staining is not a sensitive assay for cell 
wall phenotypes.  
K63-linkages are known to be involved in at least some Rsp5-mediated processes, 
including endocytosis of plasma-membrane proteins such as Gap1 and Fur4 (66, 206) and 
regulation of mitochondrial distribution (64). There is no direct evidence that K63-
linkages are involved in activation of Spt23 or the RNA export function of Rsp5, and we 
cannot rule out the possibility that other types of chains are catalyzed by Rsp5 in these 
pathways.  It was previously proposed that Spt23 is monoubiquitinated by Rsp5 (180). 
While the vast majority of polyubiquitin chains that accumulated in the ubp2∆ cells were 
K63-linked, a small increase in total conjugates seen in the ubp2∆/K63R suggested that 
Ubp2 may be capable of catalyzing deconjugation of other types of chains, or possibly 
removing monoubiquitin linkages from target proteins. With regard to the latter, Ubp2 
can reverse the in vitro ubiquitination of certain Rsp5 substrates completely, regenerating 
the unmodified target protein (120) (see Chapter 2).  However, the small increase of 
ubiquitin conjugates in ubp2∆ mutants might represent monoubiquitinated species, 
  128 
raising an interesting possibility that Ubp2 might have cooperative function in promoting 
the monoubiquitination with Rsp5 for some substrates, where Rsp5 first catalyzes 
polyubiquitination of a substrate, with Ubp2 generating a monoubiquitinated form of the 
protein by disassembly of the chain but leaving the proximal ubiquitin in place (see 
Chapter 4 for further discussion). This might explain how Rsp5, which appears to be a 
highly processive enzyme in vitro on most of the substrates,, can generate 
monoubiquitinated proteins in vivo, such as monoubiquitinated Spt23, Rvs167, or Vps9 
(180, 204, 209).   
Data described in this chapter suggest that Rsp5 and Ubp2 balance at least some 
of the physiological processes in yeast, including cell wall biogenesis and ADCB 
sensitivity. The regulatory mechanism of Rsp5 and Ubp2 was shown to primarily involve 
K63-linked polyubiquitin chains. Illustration 3.2 describes the model for the balanced 
activity of Rsp5 and Ubp2. ubp2∆ cells seem to have no obvious phenotypes under 
physiologically normal condition, suggesting that hyperactivity of Rsp5 is not harmful for 
the normally growing cells. Alternatively, it is conceivable that there might be another 
DUB that plays a redundant role in terms of Rsp5 activity, although this is not likely the 
case because the only K63-specific DUB activity copurified with Rsp5 seems to be Ubp2 
(see figure 5.1 in Chapter 5). The ubp2∆ mutant, however, displays hypersensitivity to 
ADCB, suggesting that the accumulation of K63-linked polyubiquitination of one or 
more substrates can be toxic under stress conditions. The ADCB sensitivities of ubp2∆ or 
rup1∆ have been suggested to be linked to the Gap1 general amino acid transporter 
activity, since the mutations led to the stabilization of the GFP-Gap1 in the 
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plasmamembrane under nitrogen-replete condition, where Gap1 is normally destabilized 
by endocytosis (182). However, the basis for the ADCB sensitivity in ubp2∆ mutants is 
complicated by the fact that K63R ubiquitin, which presumably inhibits Gap1 
internalization (206), rescues the phenotype. Therefore, I hypothesize that accumulation 
of one or more of the K63-linked substrates, with unknown identities, confer sensitivity 
to the drug. Consistent with this notion, ubp2∆ mutant was shown to be sensitive to 







Illustration 3.2 Model for the regulation of K63-linked polyubiquitination by Rsp5 and 
Ubp2. Rsp5 and Ubp2 regulate K63-linked polyubiquitination of unknown substrates 
(see discussion in chapter 4). Accumulation of one or more of K63-linked 
polyubiquitinated substrates lead to hypersensitivity to ADCB, while defect in Rsp5 
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Unlike the well-characterized role of K48-linkages in targeting proteins to the 26S 
proteasome, the biochemical function of the K63-linkages is unclear. The function is 
generally considered to be non-proteolytic, with the best-characterized examples being in 
the NFkB signaling pathway, DNA repair pathway, and ubiquitin-mediated endocytosis. 
It has been suggested that K63-linked conjugation of certain substrate can be recognized 
by the proteasome in vitro (187), however the fact that K63 conjugates accumulate in 
ubp2∆ cells suggest that at least the bulk of K63-conjugated Rsp5 substrates are not 
shunted to the proteasome.  The structure of K63-linked polyubiquitin chains are distinct 
from K48 chains (Illustration 2.3) (221), consistent with distinct functional roles of the 
chain types.  The identification of Rsp5 and Rup1/Ubp2 as a group of enzymes that 
specifically modulate K63 chain formation in vivo will allow further exploration of the 
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4.1 Introduction 
 Rsp5 and Ubp2 form a stable complex to regulate a set of K63-linked 
polyubiquitination in S. cerevisae (120, 121). Although it is not known whether a subset 
or all the of Rsp5 substrates are regulated by Ubp2 in the cells, it appears that 
deubiquitination of significant pool of the Ubp2 substrates are dependent on Rsp5 activity, 
based on the analysis of the total ubiquitin conjugates (see Chapter 3). Furthermore, 
Ubp2 was shown to affect at least some of the Rsp5-mediated processes, including 
endocytic pathways (182), OLE pathway, and cell wall biogenesis (Chapter 2 and 3). 
However, identities of the specific substrates that are subject to co-regulation by Rsp5 
and Ubp2 are unknown, as are the substrates conjugated via K63-linkages in cells, in 
general. The fact that the bulk of K63-linked conjugates are detected in the ubp2∆ cells 
indicates that the ubp2∆ cells provide an excellent tool for enriching the ubiquitinated 
conjugates, particularly K63-linkages, for subsequent purification and identification by 
mass spectrometry. Furthermore, these conjugates appear to be stable in the cell extracts, 
indicating that the conjugates are highly resistant to promiscuous proteolytic activities 
present in the extracts. Therefore, I set out to purify the ubiquitinated conjugates to better 
understand the regulatory mechanisms of Rsp5 and Ubp2.  
 Previous attempts to purify Rsp5-associated proteins led to the identification of 
several proteins, such as Ubp2, Bul1, and Rup1 (107, 120), These proteins appear to be 
stably interacting co-factors of Rsp5, rather than substrates of the E3 ligase (see Chapter 
2). This suggests that the previous methods are not suitable for purifying less stable and 
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transient substrate proteins. Therefore, an alternative purification scheme is necessary for 
isolating the ubiquitinated proteins. 
 Here, I describe an alternative approach for identifying the ubiquitinated 
substrates of Rsp5, using a two-step purification method. The mass spectrometry analysis 
revealed many potential targets of Rsp5, including Rpb1. Two previously uncharacterized 
proteins, Csr2 and Ecm21, were among the target proteins identified and shown to be 
ubiquitinated by Rsp5 via K63-linkages and deubiquitinated by Ubp2 in vitro. Together, 
these results suggest that this modified proteomic approach might be useful in identifying 
an array of target proteins of Rsp5 and Ubp2 complex and provide basis for 
characterizing the regulatory mechanisms of Rsp5 in synthesizing K63-linkages. 











  134 
4.2 Materials and methods 
Yeast strains, media, and plasmids 
A list of yeast strains is shown in Table 1. csr2∆ and ecm21∆ mutations were introduced 
into FW1808 strain using the same method to generate YK028 and YK029, respectively, 
using the PCR-based recombination methods as described in Chapter 2. The rup1∆ 
mutation was introduced into YK009 strain using HIS3 selection, generating YK030. 
pUB39 is a URA3-marked plasmid that expresses wild type ubiquitin under the CUP1 
promoter and pUB197 is identical to pUB39, except for the K63R mutation (208) (see 
materials and methods in Chapter 3). CSR2 and ECM21 ORFs were PCR amplified from 
genomic DNA and cloned into the pYES2 vector encoding an N-terminal HA-epitope for 
in vitro and in vivo expression. For the expression of N-terminally TAP-tagged ubiquitin, 
the UBI4 ORF was subcloned into the pYES2-NTAP vector (120). The C-terminal 
codons of UBI4 encoding GG altered to AA codons for expression of NTAP-Ub-AA75-76. 
For the CFW containing media, CFW (Sigma) was dissolved in water and added to YPD 
media as final concentrations of 5 or 7ug/ml where indicated. 
 
Purification of ubiquitinated proteins  
For the large scale purification of ubiquitinated proteins, 6 liters of ubp2∆ cells 
containing the N-terminally TAP-tagged ubiquitin were grown and the expression of 
tagged ubiquitin was induced by switching the cells to galactose media over night. Cell 
lysate was prepared as described above. IgG sepharose (Amersham Biosciences) was 
added to the cleared lysate and rotated for 2 hours at 4°C. The beads were washed 2 times 
  135 
with the NP40 buffer and the final wash was done with TEV buffer (0.1% NP40, 150mM 
NaCl, 50mM Tris pH 7.0, 1mM DTT), before adding TEV protease to the beads. The 
TEV cleavage reaction was done for 2 hours at room temperature on a rotator. The eluted 
ubiquitinated proteins were purified on GST-Rsp5C777A (GST-Rsp5-C-A) immobilized 
on glutathione sepharose by incubation for 2 hours at 4°C. The sepharose was washed 2 
times with the 1% NP40 buffer followed by 0.1% NP40 buffer as a final wash, before 
they were analyzed on 10% SDS-PAGE gel and stained by Coomassie blue.  For 
purification of endogenous ubiquitinated proteins, cell extracts were prepared using same 
method from 6L of ubp2∆ cells grown in YPD and bound to either GST-Rsp5-C-A or 
GST-Ubp2-C-S that are immobilized on glutathione sepahrose. Bands were excised from 
a Coomassie blue stained gel and subjected to in gel-tryptic digest. The fragmented 
peptides were analyzed by LC/MS (City of Hope mass spectrometry facility). 
 
Protein interaction assays 
GST-fusions of Rsp5 and Ubp2C-S were expressed from pGEX6p-1 in 
Escherichia.coli DH5α and purified on glutathione sepharose, as described previously 
(120). 35S-labeled Csr2 and Ecm21 were produced using a coupled in vitro 
transcription/translation rabbit reticulocyte system (Promega) for in vitro GST-pulldown 
assays. The translated products were bound to GST-Rsp5 immobilized on glutathione 
sepharose for 2 hours at 4°C before they were analyzed on SDS-PAGE gel and 
autoradiography. HA-tagged Csr2 and Ecm21 were expressed under galactose induction 
in either wild type (FY56) or NTAP-RSP5 (YK001) strain. Approximately 30 O.D. of 
  136 
cells were grown and resuspended with 1% NP40 lysis buffer (1% NP-40, 150mM NaCl, 
10mM Tris 8.0) supplemented with protease inhibitors before the cells were broken up by 
bead beater. The extracts were cleared by centrifugating at 13000 rpm for 10 minutes and 
20ul of IgG sepharose (Sigma) were added to the cleared cell extracts. After 2 hours of 
incubation at 4C, beads were collected by centrifugating at 25,000 rpm, washed with the 
same buffer 3 times, and resuspended with 1X SDS-loading buffer before analyzed by 
8% SDS-PAGE. The gels were electroblotted onto nitrocellulose membrane for western 
blotting analysis. The presence of HA-Csr2 and Ecm21 was analyzed by anti-HA 
antibody (Santacruz biotech.) and NTAP-Rsp5 was analyzed by anti-TAP antibody 
(Rockland). 
 
In vitro ubiquitination/deubiquitination assays 
In vitro ubiquitination and deubiquitination assays were performed in the presence 
of 10mM Tris pH 7.5, 50mM NaCl, 5mM ATP, 5mM MgCl2, 0.1mM DTT, and 50ug/ml 
ubiquitin (Sigma). Bacterially expressed Rsp5, Rup1, and Ubp2 were purified on 
glutathione sepharose and GST was removed by cleavage with PreScission protease 
(Amersham Biosciences). In vitro translated 35S-labeled Csr2 or Ecm21, synthesized 
using transcription and translation coupled (TNT) rabbit reticulocyte lysate (Promega), 
were used as substrates. The ubiquitination reactions were performed as previously 
described (120). Ubiquitination reactions were carried out for 30 min at room 
temperature, followed by an additional 30 min for deubiquitination by Rup1/Ubp2. For 
the assays using K0, K48-only, K63-only ubiquitin (Boston Biochem), the in vitro 
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translated substrates were partially purified by DEAE anion exchange column to remove 
endogenous ubiquitin. The reactions were performed as describe above and stopped by 
addition of SDS-PAGE loading buffer and the samples were analyzed on 8% SDS-PAGE 
gel, followed by autoradiography. The deubiquitination assays using free ubiquitin chains 
utilized 3 mg of either K48 or K63 polyubiquitin chains 3-7 (Boston Biochem), and were 
incubated with 0.15–15 ng of Ubp2 for 1 h at room temperature in buffer containing 
10mM Tris pH 7.5, 50mM NaCl, 5mM MgCl2, and 0.1mM DTT. The reactions were 
stopped by SDS–PAGE loading buffer and products were analyzed by 12% SDS–PAGE 



































Strain Genotype References 
FY56 MATα his4-912δR5 lys2-128∆ ura3-52 (107) 
FW1808 MATα rsp5-1 his4-912δR5 lys2-128∆ ura3-52 (107) 
BY4741 MATa his3 leu2 met15 ura3 Open Biosystems 
YK009 MATa ubp2∆::KanMX6 his3 leu2 met15 ura3 Open Biosystems 
YK028 MATα rsp5-1 csr2∆ ::KanMX6 his4-912δR5 lys2-128∆ ura3-52 (121) 
YK029 MATα rsp5-1 ecm21∆::KanMX6 his4-912δR5 lys2-128∆ ura3-52 (121) 
YK030 MATa ubp2∆::KanMX6 rup1∆::HIS3 leu2 met15 ura3 (121) 
YK032 MATa ubp3∆::KanMX6 his3 leu2 met15 ura3 Open Biosystems 
YK033 MATa ubp4∆ ::KanMX6 his3 leu2 met15 ura3 Open Biosystems 
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4.3 Results 
 Physical association of K63-conjugated proteins with Rsp5 and Ubp2 
          Rsp5 has been shown to form direct and stable complexes in vitro with several of 
its substrates, generally mediated by the WW domains of Rsp5 and proline-containing 
motifs in the substrate proteins (227). The stable interactions between Rsp5 and its 
substrates seem to persist even after the substrates are ubiquitinated at least in vitro, as it 
was shown that the ubiquitinated forms of WBP2 still associate with GST-Rsp5 in 
pulldown assays (not shown). Because the K63 conjugates that accumulate in the ubp2∆ 
mutant are at least largely the result of Rsp5 ubiquitination activity, we predicted that 
conjugates in total ubp2∆ cell extract might stably interact with purified GST-Rsp5 in 
vitro. To test this, extracts were made from UBP2 wild-type cells, ubp2∆, ubp3∆, and 
ubp4∆ mutant cells. While ubp3∆ and ubp4∆ mutant cells also accumulate ubiquitin 
conjugates to some degree (Figure 4.1), there is no known relationship between Rsp5 and 
either Ubp3 or Ubp4, and we therefore did not expect ubiquitinated proteins in these 
extracts to interact with Rsp5. As shown in Figure 4.1, GST-Rsp5 bound a large fraction 
of the input conjugates from the ubp2∆ cell extract, but not from any of the control 
extracts. This further substantiates that the conjugates that accumulate in the ubp2∆ 








































Figure 4.1 Binding of ubiquitin conjugates in ubp2∆ cells to GST-Rsp5. 
Total cell extracts were prepared from wild type (BY4741), ubp2∆ (YK009), ubp3∆ 
(YK032), and ubp4∆ (YK033) strains and incubated with bacterially purified GST-
Rsp5, immobilized on glutathione sepharose. Bound proteins were analyzed by SDS-




Since the enrichment of the conjugates in ubp2∆ cells are due to the lack of Ubp2 
activity (see Chapter 3), these conjugates are likely to be the direct substrates of Ubp2. 
Therefore, I predicted that the ubiquitin conjugates in ubp2∆ cells might be purified using 
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catalytically inactive GST-Ubp2 CS. As negative controls for the pulldown assay, Ubp6, 
a UBP member in yeast that associate with proteasome and another HECT E3, E6AP, 
was used. As expected, GST-Ubp2CS also bound to a significant fraction of conjugates 
in extract from ubp2∆ cells (Figure 4.2A and B), while GST-Ubp6 or another HECT E3, 
GST-E6AP, did not (Figure 4.2B). Because GST-Ubp2 can bind to Rup1 and Rsp5 
present in cell extract (120), it was possible that the binding of GST-Ubp2 to conjugates 
was indirect and through Rup1 and Rsp5. This appears likely, since association of the 
conjugates with GST-Ubp2 was significantly decreased in the ubp2∆rup1∆ double 
mutant (Figure 4.2A). However, a fraction of the conjugates were still bound in the 
absence of Rup1, suggesting that Ubp2 may be able to recognize some of its targets 
directly. This is consistent with the fact that Ubp2 can disassemble free K63-linked 
chains in vitro and can deubiquitinate Rsp5 substrates in vitro in the absence of Rup1, 




































































































Figure 4.2 Binding of ubiquitin conjugates in ubp2∆ cells to GST-Ubp2-C-S. A. Cell 
extracts were prepared from wild type (BY4741), ubp2∆ (YK009), and ubp2∆rup1∆ 
(YK030) strains and incubated with GST control or GST-Ubp2-C-S immobilized on 
glutathione sepharose. Bound proteins were analyzed by SDS-PAGE and 
immunoblotting with anti-ubiquitin antibody. B. Cell extracts from ubp2∆ cells 
(YK009) were incubated with GST-Rsp5, GST-E6AP, GST-Ubp2-C-S, and GST-Ubp6 
proteins immobilized on glutathione sepharose and analyzed as in A. 
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           It is not known whether all targets of Rsp5, or only a subset of Rsp5 targets, are 
subject to potential regulation by Ubp2. The results shown in figure 4.1 suggested that we 
could identify the Ubp2-responsive substrates of Rsp5 by mass spectrometry-based 
identification of the proteins in the GST-Rsp5 pull-down from ubp2∆ cell extract. For 
this purpose, I expressed amino-terminally TAP-tagged ubiquitin in ubp2∆ cells (177). 
Since it was shown that GST-ubiquitin can be efficiently utilized for conjugation in vitro 
(250), I reasoned that the TAP-tag, which is about similar size as GST, would be used for 
substrate ubiquitination in yeast cells. Whether or not cells can utilize the TAP-tagged 
ubiquitin as sole source of ubiquitin is unknown. TAP-ubiquitin conjugates were isolated 
on IgG sepharose, and the conjugates were released from IgG sepharose by cleavage of 
the TAP tag with TEV protease. As shown in figure 4.3A, the TAP-tagged ubiquitin 
formed conjugates in ubp2∆ cells, and the conjugates could be efficiently purified on IgG 
sepharose. To exclude the possibility that TAP-ubiquitin was merely serving as an 
acceptor for endogenous ubiquitin, thereby forming free polyubiquitin conjugates, TAP-
ubiquitin was expressed in which the terminal di-glycine residues were altered to alanine 
residues (TAP-Ub-AA75-76).  The expectation was that since the TAP-Ub-AA75-76 is 
incompetent for conjugation, IgG purification should not result in purification of 
ubiquitin conjugates. As expected, no significant accumulation or purification of 
ubiquitin conjugates was detected with the AA75-76 mutant, indicating that the wild-type 
TAP-ubiquitin was indeed being conjugated to target proteins.   
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Figure 4.3 Purification of ubiquitin conjugates on GST-Rsp5. A. Purification scheme.  
B. N-terminally TAP-tagged wild type ubiquitin or ubiquitin AA75-76 were expressed in 
ubp2∆ cells and conjugates purified on IgG sepharose. The samples were analyzed by 
SDS-PAGE and immunoblotting with anti-TAP antibody. C.  Coomassie blue-stained 
gel of final eluates. 6 liters of the ubp2∆ cells expressing NTAP-Ub were subject to IgG 
sepharose, cleaved with TEV, and then purified on GST-Rsp5C-A immobilized on 
glutathione sepharose. The bound proteins were boiled in SDS-PAGE loading buffer 
and analyzed on 10% SDS-PAGE gel followed by Coomassie blue staining. 
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The purification was scaled up (starting with 6 liters of cells at O.D.600 of 1.5) for 
the two-step purification. First, IgG-sepharose was used for the first step purification to 
isolate substrates that are conjugated with TAP-ubiquitin. The conjugates were eluted 
with TEV protease and bacterially purified GST-Rsp5 immobilized on glutathione 
sepharose was used to purify Rsp5-specific ubiquitinated proteins. Figure 4.3C shows an 
example of a Coomassie blue-stained gel of the final eluate from a large-scale 
purification. As we were interested initially in the identity of the high molecular weight 
conjugates, the region of the gel above the migration point of GST-Rsp5-C-A was cut 
into several pieces and subject to mass spectrometry protein identification. As was the 
case in the NTAP-Rsp5 purification described in chapter 2, I speculated that most of the 
detectable protein bands lower than the size of GST-Rsp5 were degradation products of 
Rsp5. In separate large-scale experiments, GST-Rsp5-C-A as well as GST-Ubp2-C-S 
proteins immobilized on glutathione sepharose were also used to directly purify 
putatively ubiquitinated proteins from 6 liters of ubp2∆ cell extracts in one-step 
purification (Figure 4.2). Table 1 shows complete list of the proteins identified in 
multiple purifications which used GST-Rsp5-C-A proteins as baits, and Table 2 shows 
list of proteins identified in purifications used GST-Ubp2-C-S as bait. Rpb1, the largest 
subunit of RNA polymerase II, was identified again in this purification, strongly 
suggesting that it is a direct ubiquitination target of Rsp5 (107, 120) and shown to be the 
most abundant protein among the list of the proteins identified. Several proteins involved 
in RNA processing (Xrn1, Slh1, Rrp5, and Sen1) were among the proteins identified in 
the GST-Rsp5 purification, potentially suggesting that these might be unknown proteins 
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involved in the Rsp5-mediated RNA processing and/or nuclear export. Particularly, Sen1 
contains multiple PxY or PY motifs, suggesting that it may directly bind to the WW 
domains of Rsp5. Rod1, a PxY motif-containing protein previously reported to bind to 
Rsp5 and implicated in drug resistance (7), was included in the list albeit in a small 
quantity, suggesting that the proteomic method isolates physiologically relevant target 
proteins. Notably, Pma1 and Ecm21 were identified in both GST-Rsp5 and GST-Ubp2 
pulldown experiments, suggesting that these might be common substrates of Rsp5 and 
Ubp2. Interestingly, the activity of Pma1, the plasmamembrane H+-ATPase, was 
genetically shown to be regulated by both Rsp5 and Ubp2 (40), further suggesting that it 
might be a direct target of both proteins. Rup1 was not isolated in the purification, 
suggesting that it is not significantly ubiquitinated by Rsp5, although it was shown to be 
ubiquitinated in vitro (not shown). Interestingly, Bul1, protein that binds to Rsp5 via its 
PPxY motif (243, 244), was among the list, suggesting that it might be ubiquitinated in 
the cells. It was also isolated in a previous proteomic studies that identified total 
ubiquitinated proteins from cells (171) and, in fact, it is efficiently ubiquitinated in vitro 
by Rsp5 in a PPxY motif-dependent manner (our unpublished result). It still remains 
unknown whether Rsp5-mediated ubiquitination of Bul1 and Bul2, two proteins that are 
known as cofactors of Rsp5 (206), has physiological relevance. Two proteins with 
unknown molecular function, Csr2 and Ecm21, were among the list and they were further 
analyzed in rest of the chapter. 
 
 








Rpb1 YDL140C RNA polymerase II large subunit. Shown to be a substrate of Rsp5 
Xrn1 YGL173C 
5'-3' exonuclease component of cytoplasmic processing (P) bodies 
involved in mRNA decay. Also plays role in ribosomal RNA 
maturation 
Csr2 YPR030W Putatively involved in cell wall biogenesis 
Ecm21 YBL101C Putatively involved in chitin synthesis 
Slh1 YGR271W Putative RNA helicase related to Ski2p, involved in translation inhibition of non-poly(A) mRNAs 
Tom1 YDR457W 
E3 ubiquitin ligase of the Hect-domain class; has a role in mRNA 
export from the nucleus and may regulate transcriptional 
coactivators 
Sen1 YJR430W 
Nuclear protein, putative helicase required for processing of 
tRNAs, rRNAs, and small nuclear RNAs; potential Cdc28p 
substrate 
Rrp5 YMR229C Protein required for the synthesis of both 18S and 5.8S rRNA. Component of ribosomal subunit 
Rpb2 YOR151C RNA polymerase II second largest subunit B150 
Spt5 YML010W 
Protein that forms a complex with Spt4 and mediates both 
activation and inhibition of transcription elongation. Also plays 
role in pre-mRNA processing 
Pma1 YGL008C Plasma membrane H+-ATPase, pumps protons out of the cell 
Bul1 YMR275C Functional homolog of Bul2, overexpression causes missorting of amino acid permease. Shown to bind to Rsp5 
Rpa1 YAR007C 
Subunit of Replication Factor A (RF-A), a highly conserved 
single-stranded DNA binding protein involved in DNA replication, 
repair, and recombination 
Rod1 YOR018W 
Membrane protein; overexpression confers resistance to the GST 
substrate o-dinitrobenzene as well as to zinc and calcium. Shown 
to bind to Rsp5 
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Rsp5 YER125W A multifunctional HECT-domain E3 ligase 
Ecm21 YPR030W Putatively involved in cell wall biogenesis 
Pma1 YGL008C Plasma membrane H+-ATPase, pumps protons out of the cell 
 
 






Csr2 and Ecm21 are closely related proteins of approximately 125 kDa (Figure 
4.4A), although both migrate as approximately 145 kDa on SDS-PAGE gels. Both have 
been shown previously to be ubiquitinated in vivo (156, 171, 216), although no 
connection to Rsp5 or Ubp2 was previously noted. Csr2 and Ecm21 are divergent over 
their first 180 amino acids, and are 32% identical over the remainder of their sequence. 
There are no identifiable motifs or functional domains and no biochemical function has 
been assigned to either protein, except for the fact that both proteins contain multiple 
PxY and PPxY motifs, suggesting that they might directly bind to WW domains of Rsp5. 
CSR2 was previously isolated as a multicopy suppressor of a chs5spa2 mutant, which 
exhibits aberrant cell wall structure and a defect in polarized cell growth (190). The 
ecm21∆ mutant was shown to be synthetically lethal with chs1∆ and chs5∆, which are 
essential for chitin synthesis, suggesting a role for Ecm21 in cell wall integrity (219). 
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Since Rsp5 activity is previously implicated in cell wall biogenesis (121) (see Chapter 3) 
and the proteomics study suggests that Csr2 and Ecm21 are ubiquitinated proteins that 
bind to Rsp5, I decided to further investigate these two proteins in terms of regulation by 
Rsp5 and Ubp2. 
First, direct binding activities of Csr2 and Ecm21 to Rsp5 were investigated. In 
vitro translated (rabbit reticulocyte lysate) 35S-labelled Csr2 and Ecm21 was shown to 
bind efficiently to purified GST-Rsp5, while an unrelated protein (in vitro translated p53) 
did not (Figure 4.4B), suggesting that they bind directly to Rsp5. Preliminary domain 
mapping study did not reveal the determinants in Csr2 and Ecm21 required for binding to 
Rsp5, although it was shown that the C-terminal PPRY sequences in both proteins are 
dispensable for the interactions, suggesting that other upstream PxY motifs might be 
involved in the interactions. To test if Csr2 and Ecm21 are associated with Rsp5 in cells, 
HA-tagged Csr2 and Ecm21 were expressed in the TAP-RSP5 (YK001) strain and 
pulldown experiments were performed. As expected, both HA-Csr2 and Ecm21 proteins 
were detected in the TAP-Rsp5 pulldown, suggesting that they associate with Rsp5 in 


















































































Figure 4.4 Csr2 and Ecm21 bind to Rsp5. A. Schematic diagram for overall sequence 
homology between Csr2 and Ecm21. B. In vitro translated 35S-labeled Csr2 or Ecm21 
were incubated with GST-Rsp5 immobilized on glutathione sepharose. Bound proteins 
were detected by SDS-PAGE and autoradiography. In vitro translated p53 was used as 
a negative control. C. HA-tagged Csr2 and Ecm21 were overexpressed in either wild 
type (FY56) strain or NTAP-RSP5 (YK001) strain. Cell extracts were prepared and 
NTAP-Rsp5 was purified using IgG sepahrose and HA-proteins were detected by anti-
HA western blotting.   
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Figure 4.5 shows that Rsp5 efficiently polyubiquitinated in vitro translated Csr2 
and Ecm21. To test whether Csr2 and Ecm21 were polyubiquitinated via K63-linkages, 
the in vitro assay was performed in the presence of ubiquitin mutants (Figure 4.5B). The 
efficiency of polyubiquitination of Csr2 and Ecm21 was comparable when using wild 
type ubiquitin and K63-only ubiquitin, while the length of the chains was shorter with 
K48-only ubiquitin. The K48-only products were similar to those with K0 (no lysine) 
ubiquitin, suggesting that the majority of the products formed with K48-only ubiquitin 
are likely to represent multiple lysines being modified with single ubiquitin moieties. 
This is consistent with a previous report that multiple lysine residues of Ecm21 are 
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Figure 4.5 Csr2 and Ecm21 are substrates of Rsp5. A. In vitro translated 35S-labeled 
Csr2 or Ecm21 were incubated with E1, E2, Ub, and ATP in the presence or absence of 
Rsp5 as described in materials and methods. Reactions were stopped after 30 min and 
the products were analyzed on SDS-PAGE and autoradiography. B. Rsp5-catalyzed 
ubiquitination reactions were carried out as in A, except that the endogenous ubiquitin 
present in the translated reactions were first removed by anion exchange 
chromatography. The reactions were then performed in the absence of added ubiquitin 
(lane 2) or the presence of wild type ubiquitin, K0 ubiquitin, K48-only ubiquitin, and 
K63-only ubiquitin (lanes 3-6).  Products were analyzed as in B.  
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Rsp5   - +    +    +   - +    +    +

















Figure 4.6 Ubp2 deubiquitinates Csr2 and Ecm21 in vitro. In vitro translated 35S-
labeled Csr2 or Ecm21 were incubated with E1, E2, Ub, and ATP in the presence or 
absence of Rsp5 as previously in figure 5. After 30 minutes of ubiquitination, Rup1 and 
Ubp2 proteins were added and additional 30 minutes were incubated. The final 




Figure 4.6 shows that the subsequent addition of Rup1 and Ubp2 to the Rsp5-
catalyzed reaction led to deubiquitination of both Ecm21 and Csr2. Interestingly, we 
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did not observe recovery of the unmodified proteins even in the presence of excess 
amount of Ubp2, suggesting that Ubp2 may be unable to cleave the most proximal 
ubiquitin moieties from these substrates. This suggests a possible mechanism for 
generation of monoubiquitinated proteins by the combined actions of Rsp5 and Ubp2. 
Since both CSR2 and ECM21 were previously implicated in cell wall biogenesis 
(190, 219) and Rsp5 has shown to be involved in cell wall biogenesis as well (121) (see 
Chapter 3), I investigated the potential genetic interactions between CSR2/ECM21 and 
RSP5 in the context of calcofluor white (CFW) sensitivity. While neither the ecm21∆ nor 
csr2∆ mutations lead to either enhanced or resistant sensitivity to CFW (not shown), both 
mutations partially suppressed the CFW sensitivity of the rsp5-1 mutation (Figure 4.7). 
This suggests that deficient ubiquitination of either Csr2 or Ecm21 in the rsp5-1 
hypomorphic mutants might be at least the partial cause of the enhanced sensitivity of the 
strain to CFW, as eliminating either of the proteins resulted in partial rescue to the drug. 
This suggests a hypothetical model in which an abundance of unmodified Csr2 or Ecm21 
leads to cell wall instability, while ubiquitination of Csr2/Ecm21, or lack of Csr2/Ecm21 
entirely, leads to cell wall stabilization. The deletion of csr2 or ecm21 did not rescue the 
temperature sensitivity of the rsp5-1 mutant, and multi-copy overexpression of either 
CSR2 or ECM21 changed neither CFW sensitivity nor temperature sensitivity of the rsp5-






























Figure 4.7 Deletions of either csr2 or ecm21 partially rescues rsp5-1 phenotype. Wild 
type RSP5 (FY56), rsp5-1 (FW1808), rsp5-1∆csr2 (YK028), and rsp5-1∆ecm21 
(YK029) cells were serially 6-fold diluted and spotted on either YPD or YPD 
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4.4 Discussion 
In this chapter, I described a proteomic approach for isolating ubiquitinated 
proteins that bind to Rsp5. Although it was not expected that the large TAP-tagging 
(~20kDa) of ubiquitin to be conjugated to all of the natural target proteins in cells, the 
TAP-ubiquitin have shown to be capable of being conjugated to at least some of the 
proteins (Figure 4.3B). Recently, there have been several reports that systematically 
isolated ubiquitinated conjugates from cells using various methods (156, 171, 216). All of 
these purifications were done under denaturing conditions using histidine-tagged 
ubiquitin, since the ubiquitination is sensitive to relatively abundant deubiquitinating 
enzymes present in the cell extracts. However, since the second step of my purification 
method requires naturally folded proteins that bind to GST-Rsp5, it was impossible to use 
denatured cell extracts. Furthermore, I did not expect that denaturing conditions were 
necessary for this purification project, since the increased K63-linked polyubiquitin 
chains in the ubp2∆ mutant cells appear highly stable in the cell extracts, unlike the K48-
linked polyubiquitin chains that normally undergo rapid proteosomal-mediated 
degradation. This indirectly suggests that the K63-linked polyubiquitin chains might not 
be natural targets of proteasome in the cell extracts. Furthermore, specific DUB inhibitors 
such as NEM (N-ethylmaleimide) have been shown to efficiently block any promiscuous 
DUB activities in the cell extracts.  
I isolated two closely related but largely uncharacterized proteins, Csr2 and 
Ecm21, as substrates of Rsp5, both of which appear related to cell wall integrity. CSR2 
was isolated as a multicopy suppressor of a chs5∆spa2∆ mutant, which exhibits aberrant 
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cell wall structure and a defect in polarized cell growth (190). ecm21∆ mutation was 
shown to be synthetically lethal with chs1∆ and chs5∆ (219), both of which are essential 
for chitin synthesis, together suggesting that Csr2 and Ecm21 might be involved in a cell 
wall integrity pathway. Neither ecm21∆ nor csr2∆ mutations lead to either enhanced 
sensitivity or resistance to CFW. However, deletion of either ecm21∆ or csr2∆ partially 
rescued the CFW sensitivity of rsp5-1, suggesting possible roles of these proteins in the 
Rsp5-mediated cell wall homeostasis. It is possible that deletion of both csr2 and ecm21 
simultaneously in the rsp5-1 background might lead to further enhanced rescue of the 
mutant toward CFW, although the csr2∆ecm21∆ double deletion mutant in RSP5 wild 
type background was not shown to display either decreased or increased sensitivity to 
CFW (not shown).  
Although both Csr2 and Ecm21 were previously shown to be ubiquitinated in vivo 
in large-scale ubiquitin proteomic projects (156, 171, 216), specific E3 enzymes 
responsible for their modification were not known. Csr2 and Ecm21 were both efficiently 
ubiquitinated via K63-linkages by Rsp5 in vitro, consistent with the fact that: 1) the 
CFW-sensitive phenotype of rsp5-1 strain was rescued by overexpressing wild type 
ubiquitin, but not K63R ubiquitin, and 2) a strain expressing K63R-only ubiquitin as the 
sole source of ubiquitin was also sensitive to CFW (121) (Chapter 3). Therefore, we 
propose that Rsp5-catalyzed K63-ubiquitination of specific targets proteins, including but 
perhaps not limited to Csr2 and Ecm21, promotes cell wall biogenesis and/or stability. It 
remains to be determined whether Csr2 and Ecm21 are indeed modified via K63-linked 
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polyubiquitination by Rsp5 in the cells and what the precise biochemical functions of 
Csr2 and Ecm21 are and how these affect Rsp5-mediated cell wall homeostasis. 
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In this work, I have shown that Rsp5 is physically coupled to the Ubp2 
deubiquitinating enzyme and that its ability to catalyze K63-linked polyubiquitination is 
counterbalanced by the K63-linkage specific activity of Ubp2. This work provides 
opportunities to answer several important questions with regard to the regulation of 
HECT E3s and mechanisms of polyubiquitin chain synthesis. 
 
Regulation of Rsp5/Ubp2 complex 
 The most important aspect of this work is that it represents a unique 
demonstration of a negative regulatory mechanism for a HECT E3 ligase. Our lab has 
long observed that Rsp5 efficiently produces polyubiquitination of its substrates in vitro, 
while several reports have shown that Rsp5 mediates mono- or short K63-linked 
polyubiquitination on several substrates in vivo, suggesting that there might be an 
unknown mechanism that is not reflected in the in vitro assays. My work suggests that, 
by being physically coupled to Ubp2, the inherently processive activity of Rsp5 might be 
counter-balanced to achieve regulated ubiquitination, or alternatively, to produce mono- 
or short oligo- K63-linkages. The former is consistent with our genetic studies (Chapter 
2) in which the phenotype of overproduction of UBP2 mimicked that of rsp5 null mutant, 
whereas deletion of ubp2 or rup1 rescued rsp5-1 temperature sensitivity. Several pieces 
of data supported the latter scenario, however, which showed that deletion of ubp2 
resulted in stabilization of Gap1 on the plasmamembrane (182), which phenocopies rsp5 
mutation. Furthermore, the in vitro assays using Csr2 and Ecm21 showed that Ubp2 
activities do not generate complete reversion of the ubiquitinated substrates to 
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unmodified forms (Chapter 4), suggesting that Ubp2 might help promoting synthesis of 
mono- or oligo-K63-linkages. A current hypothesis is that Ubp2 might antagonize the 
majority of Rsp5-mediated K63-linked polyubiquitination, while it may promote Rsp5 
activity by assisting with the generation of mono- or oligoubiquitinated substrates. More 
comprehensive analyses of the substrates that are regulated by Rsp5 and Ubp2 will give 
us better insight. Figure 2.16 in chapter 2 showed that the polyubiquitinating activity of 
Rsp5 can be limited by coupling to Ubp2 that is present in cell extracts. Also, the data 
suggests that the only K63-linkage specific DUB associated with Rsp5 is Ubp2. Rsp5 
was not shown to associate with K48-linkage specific DUB (not shown). 
 
Regulatory mechanisms of mammalian Rsp5 homologues 
This work is the first demonstration of a physical coupling between a HECT E3 
and a DUB. It will be important to determine whether other HECT E3s also utilize a 
similar mechanism. There are nine homologues of Rsp5 in human cells, including Nedd4, 
Smurf1/2, and Itch (Illustration 5.1). Based not only on their sequence similarities but 
also based on similar functions, such as mediating endocytosis of membrane proteins 
(110), it is possible that the mammalian homologues are also regulated by similar 
mechanisms by physically associating with DUBs. The simplest and initial test for their 
potential association with DUBs might be tests for abilities of the GST-HECT E3s for 
pull-down of DUB activities from cell extracts. Interestingly, when GST-Rsp5 was pre-
incubated with HeLa cell extracts, a potential K63-linkage specific DUB was co-purified, 
whose activity was reflected in the WBP2 deubiquitination assay (not shown).  


























Illustration 5.1 A schematic diagram for nine human homologes of Rsp5. Domain colored 





This might be due to the high structural similarities between Rsp5 and its mammalian 
homologues and Rsp5 is able to interact with a potential DUB that normally associate 
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with its homologues, similar to the fact that WW domains of five different Rsp5 
homologues can interact with WBP2 (our unpublished result). An alternative approach to 
test for the potential DUB association is to use DUB-specific active-site probe ubiquitin-
vinylsulfone (UbVs). UbVs is a C-terminally modified ubiquitin derivative which 
irreversibly modifies a subset of UCHs and UBPs members, and has successfully been 
shown to label several DUBs present in cell extracts, including Ubp2 (14, 15). If a HECT 
E3 is physically associated with a DUB, the immunopurified or GST-pulled-down of the 
HECT E3 protein complexes might be labeled with UbVS. It will be of interest to 
identify the potential DUBs associated with Nedd4, Smurf1/2, or Itch and test if they 
affect the activities of the E3s. 
 
Determinants of chain type specificity 
I have shown that Rsp5 preferentially catalyzes K63-linked polyubiquitination on 
WBP2, Ecm21, and Csr2 in vitro. This apparent in vitro preference to K63-linkages is 
consistent with previous reports that Fur4 and Gap1, two membrane proteins that are 
downregulated by Rsp5, are polyubiquitinated via K63-linkages (66, 206). These results 
strongly suggest that it is the inherent activity of Rsp5 that preferably assembles K63-
linkages, not substrate-dependent activities. Likewise, E6AP assembled K48-linked 
polyubiquitination on two different substrates, p53 and Scribble, consistent with E6AP’s 
demonstrated role in the degradation of the substrates (106, 165). It is important to note 
that the in vitro assays for Rsp5 and E6AP-mediated ubiquitination produced two 
different chain linkages when same E2, UbcH7, was used (see Chapter 3), excluding the 
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possibility that E2 might be the determinant of the differential chain type synthesis. 
Furthermore, Rsp5 preferably assembled K63-linked polyubiquitination on WBP2 when 
three different E2s (yeast Ubc1, human UbcH7, Arabidopsis Ubc8) were used (Chapter 3, 
not shown). Therefore, it is likely that the determinants for the preference of the different 
chain types (e.g., K48 vs K63) lie on the E3 proteins. A next challenge is to map the 
determinants of the chain specificity within the E3s. One possible model is that the 
inherent conformation within the HECT domain might bring the thioster-conjugated 
ubiquitin to the proximity of the selective lysine (K63) on the preceding ubiquitin, which 
will allow the selective nucleophile attack from K63. Structural studies in combination 
with functional assays need to be done to test this hypothesis. The information from this 
study will give us insight into how Rsp5 promotes non-proteolytic K63-linked 
ubiquitination on its substrates, as opposed to proteolytic K48-linkages.  
The study on the chain type specificities of HECT E3s can be extended to human 
homologues of Rsp5. It was shown that human Nedd4 can functionally substitue for the 
endocytic functions of Rsp5 (65), suggesting that Nedd4 might catalyze K63-linked 
polyubiquitination of membrane-associated substrates. However, the well established 
roles of Smuf1/2 and Itch include promoting the degradation of their substrates (149, 249, 
251) (discussed in detail in Chapter 1), suggesting that they might catalyze K48-linked 
polyubiquitination. These observations present several interesting questions. Do 
Smurf1/2 and Itch promote K48-linked polyubiquitination while Nedd4 does K63? What 
is the basis for the distinct biochemical activities among the closely related homologues? 
Interestingly, a recent report demonstrated that Itch promotes K29-linked 
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polyubiquitination on its membrane-bound substrate, Deltex, leading to endocytosis. 
Does this mean Itch mediates assembly of two different chain types depending on the 
substrates? These outstanding questions need to be clarified using biochemical 
approaches to define the determinants for different chain type preferences.  
 
K63-polyubiquitinated substrates and their function 
An interesting piece of data described in chapter 3 is that a significant pool of 
K63-linked polyubiquitinated conjugates is enriched in ubp2∆ mutant cells. Considering 
our current lack of knowledge on the role of K63-linked polyubiquitination, ubp2∆ cells 
can be a useful tool for investigating the understudied ubiquitin chains types. The genetic 
studies in chapter 3 suggested that the accumulation of K63-linked substrates is 
responsible for sensitivity against the toxic drug ADCB, and for resistance to cell wall 
destabilizing drug calcofluor white, although specific substrates involved in those 
pathways still remains elusive. It will be interesting to compile a more comprehensive list 
of the specific substrates that are modified via K63-linkages in ubp2∆ and to determine 
physiological consequences of the modification on some of these substrates. For example, 
it is still unclear whether K63-polyubiquitin linked substrates are recognized and 
degraded by proteasome in cells. This issue might be able to explored using the K63-
linked conjugates in ubp2∆. 
Budding yeast has proven to be an excellent model system to address many 
fundamental problems relevant to all eukaryotic organisms. Studies on Rsp5 and Ubp2 
will lead to our enhanced understanding of not only the basis of regulatory mechanisms 
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for the mammalian HECT E3s, but also the mechanisms and functions of K63-linked 
polyubiquitination, which remains one of the most important challenges in the ubiquitin 
field. In the long run, the future work described above may assist designing effective 
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